Cyalume Technologies (CYLU) 10-K 15 Apr 14 2013 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2013	Mar. 31, 2014	Jun. 30, 2013
Document Information [Line Items]	'	'	'
Document Type	'10-K	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Trading Symbol	'CYLU	'	'
Entity Common Stock, Shares Outstanding	'	21,157,936	'
Entity Registrant Name	'Cyalume Technologies Holdings, Inc.	'	'
Entity Central Index Key	'0001335293	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'No	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$15,938,631

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Current assets:	'		'
Cash	$865		$2,695
Accounts receivable, net of allowance for doubtful accounts of $44 and $155, respectively	3,788		3,875
Inventories, net	10,782		9,597
Income taxes refundable	163		173
Deferred income taxes	3,847		652
Prepaid expenses and other current assets	463		558
Total current assets	19,908		17,550
Property, plant and equipment, net	8,001		9,177
Goodwill	7,992	[1]	8,160	[2]
Other intangible assets, net	17,948		20,190
Due from related party, net	0		3,972
Other noncurrent assets	465		28
Total assets	54,314		59,077
Current liabilities:	'		'
Line of credit	1,600		0
Current portion of notes payable	1,925		9,734
Accounts payable	6,182		2,934
Accrued expenses	2,059		2,583
Deferred revenue	80		0
Income taxes payable	97		0
Current portion of capital lease obligation	15		14
Derivatives liability	0		169
Warrants liability	6,373		0
Contingent legal obligation	3,986		0
Other current liabilities	242		0
Total current liabilities	22,559		15,434
Notes payable, net of current portion	14,969		8,394
Note payable due to related parties	2,100		2,100
Deferred income taxes	3,847		3,862
Asset retirement obligation	194		184
Capital lease obligation, net of current portion	7		22
Contingent legal obligation, noncurrent	0		3,806
Other noncurrent liabilities, net of current portion	79		0
Total liabilities	43,755		33,802
Commitments and contingencies (Note 18)	'		'
Stockholders' equity	'		'
Common stock, $0.001 par value; 100,000,000 shares authorized; 20,738,260 issued and outstanding	21		21
Additional paid-in capital	102,575		105,990
Accumulated deficit	-95,874		-80,221
Accumulated other comprehensive loss	-218		-515
Total stockholders' equity	6,504		25,275
Total liabilities and stockholders' equity	54,314		59,077
Series A Convertible Preferred Stock [Member]	'		'
Stockholders' equity	'		'
Series A convertible preferred stock, $0.001 par value; 1,000,000 shares authorized; 123,077 shares issued and outstanding	$4,055		$0
[1]	Gross amount of goodwill was approximately $67.7 million as of December 31, 2013. Accumulated impairment losses were approximately $59.7 million as of December 31, 2013.
[2]	Gross amount of goodwill was approximately $67.7 million as of December 31, 2012. Accumulated impairment losses were approximately $59.5 million as of December 31, 2012.

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, except Share data, unless otherwise specified
Accounts receivable, allowance for doubtful accounts	$44	$155
Preferred stock, shares authorized	1,000,000	'
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	20,738,260	20,738,260
Common stock, shares outstanding	20,738,260	20,738,260
Series A Convertible Preferred Stock [Member]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	123,077	123,077
Preferred stock, shares outstanding	123,077	123,077

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Loss (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Revenues	$31,760	$38,642
Cost of revenues	17,957	21,530
Gross profit	13,803	17,112
Other expenses (income):	'	'
Sales and marketing	4,903	5,515
General and administrative	11,404	7,815
Research and development	1,864	1,963
Interest expense, net	2,310	2,219
Interest expense - related party	297	19
Amortization of intangible assets	1,796	1,858
Uncollectible receivable - related party	3,862	0
Impairment loss on intangible assets	875	281
Impairment loss on goodwill	168	47,088
Impairment loss on equipment	0	273
Legal settlement	2,048	0
Change in fair value of contingent consideration	242	3,380
Change in fair value of warrants liability	525	0
Loss on extinguishment of debt - related party	2,142	0
Other expenses (income), net	58	-112
Total other expenses	32,494	70,299
Loss before income taxes	-18,691	-53,187
Benefit from income taxes	-3,038	-2,969
Net loss	-15,653	-50,218
Other comprehensive income (loss), net of tax:	'	'
Foreign currency translation adjustments	200	108
Unrealized gain on cash flow hedges, net of taxes of $(59) and $(45), respectively	97	73
Other comprehensive income	297	181
Comprehensive loss	($15,356)	($50,037)
Net loss per common share:	'	'
Basic and diluted (in dollars per share)	($1.03)	($2.76)
Weighted average shares used to compute net loss per common share:	'	'
Basic and diluted (in shares)	20,714,531	18,205,586

Consolidated_Statements_of_Com1

Consolidated Statements of Comprehensive Loss (Parenthetical) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Unrealized gain (loss) on cash flow hedges, taxes	$59	$45

Consolidated_Statements_of_Cha

Consolidated Statements of Changes in Stockholders' Equity (USD $)

Total

Series A Convertible Preferred Stock [Member]

Payment of contingent consideration liability [Member]

Litigation settlement [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Additional Paid-In Capital [Member]

Additional Paid-In Capital [Member]

Additional Paid-In Capital [Member]

Accumulated Deficit [Member]

Accumulated Deficit [Member]

Accumulated Deficit [Member]

Accumulated Other Comprehensive Loss [Member]

Accumulated Other Comprehensive Loss [Member]

Accumulated Other Comprehensive Loss [Member]

Cashless Option Exercise [Member]

Cashless Option Exercise [Member]

Cashless Option Exercise [Member]

Cashless Option Exercise [Member]

Cashless Option Exercise [Member]

In Thousands, except Share data

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Payment of contingent consideration liability [Member]

Litigation settlement [Member]

USD ($)

Payment of contingent consideration liability [Member]

Litigation settlement [Member]

USD ($)

Payment of contingent consideration liability [Member]

Litigation settlement [Member]

USD ($)

Payment of contingent consideration liability [Member]

Litigation settlement [Member]

USD ($)

Common Stock [Member]

Additional Paid-In Capital [Member]

Accumulated Deficit [Member]

Accumulated Other Comprehensive Loss [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Beginning balance at Dec. 31, 2011

$69,653

'

'

'

$18

'

'

$100,334

'

'

($30,003)

'

'

($696)

'

'

'

'

'

'

'

Beginning balance (in shares) at Dec. 31, 2011

'

'

'

'

18,311,228

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

260

'

'

'

Stock Issued During Period, Value, New Issues

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0

0

0

0

0

Repurchase and retirement of common stock (in shares)

'

'

'

'

-39,895

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repurchase and retirement of common stock

-139

'

'

'

0

'

'

-139

'

'

0

'

'

0

'

'

'

'

'

'

'

Share-based compensation (in shares)

'

'

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based compensation

503

'

'

'

0

'

'

503

'

'

0

'

'

0

'

'

'

'

'

'

'

Effect of modification of warrant terms

94

'

'

'

0

'

'

94

'

'

0

'

'

0

'

'

'

'

'

'

'

Common stock issuance (in shares)

'

'

'

'

'

2,450,000

22,500

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Common stock issuance

'

'

5,145

56

'

3

'

'

5,142

56

'

0

0

'

0

0

'

'

'

'

'

Reversal Of Forfeited Restricted Awards(In Shares)

'

'

'

'

-5,833

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Reversal of forfeited restricted awards

0

'

'

'

'

'

'

'

'

'

0

'

'

0

'

'

'

'

'

'

'

Series A convertible preferred stock issuance costs

56

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net loss

-50,218

'

'

'

'

'

'

'

'

'

-50,218

'

'

0

'

'

'

'

'

'

'

Other comprehensive income

181

'

'

'

0

'

'

0

'

'

0

'

'

181

'

'

'

'

'

'

'

Ending balance at Dec. 31, 2012

25,275

0

'

'

21

'

'

105,990

'

'

-80,221

'

'

-515

'

'

'

'

'

'

'

Ending balance (in shares) at Dec. 31, 2012

'

0

'

'

20,738,260

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Shares, New Issues

'

123,077

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, New Issues

0

4,000

'

'

0

'

'

0

'

'

0

'

'

0

'

'

'

'

'

'

'

Share-based compensation (in shares)

'

0

'

'

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share-based compensation

773

0

'

'

0

'

'

773

'

'

0

'

'

0

'

'

'

'

'

'

'

Effect of modification of warrant terms

241

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Series A convertible preferred stock issuance costs

0

0

'

'

0

'

'

-647

'

'

0

'

'

0

'

'

'

'

'

'

'

Dividends accrued on Series A convertible preferred stock

-55

55

'

'

0

'

'

-55

'

'

0

'

'

0

'

'

'

'

'

'

'

Deemed dividend on Series A convertible preferred stock

-4,000

4,000

'

'

0

'

'

-4,000

'

'

0

'

'

0

'

'

'

'

'

'

'

Excess of common warrant and preferred warrant fair value

-1,553

-4,000

'

'

0

'

'

-1,553

'

'

0

'

'

0

'

'

'

'

'

'

'

Warrants amended in connection with debt refinancing

0

0

'

'

0

'

'

0

'

'

0

'

'

0

'

'

'

'

'

'

'

Fair value of amended related party note over note face value

2,067

0

'

'

0

'

'

2,067

'

'

0

'

'

0

'

'

'

'

'

'

'

Net loss

-15,653

0

'

'

0

'

'

0

'

'

-15,653

'

'

0

'

'

'

'

'

'

'

Other comprehensive income

297

0

'

'

0

'

'

0

'

'

0

'

'

297

'

'

'

'

'

'

'

Ending balance at Dec. 31, 2013

$6,504

$4,055

'

'

$21

'

'

$102,575

'

'

($95,874)

'

'

($218)

'

'

'

'

'

'

'

Ending balance (in shares) at Dec. 31, 2013

'

123,077

'

'

20,738,260

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:	'	'
Net loss	($15,653)	($50,218)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:	'	'
Depreciation and amortization of property, plant and equipment	1,387	1,374
Amortization	2,429	2,345
Benefit from deferred income taxes	-3,328	-3,357
Share-based compensation expense	773	503
Impairment loss on equipment	0	273
Impairment loss on intangible assets	875	281
Impairment loss on goodwill	168	47,088
Change in fair value of contingent consideration	242	3,380
Change in fair value of derivatives	-14	18
Change in fair value of warrants liability	525	0
Non-cash interest expense	159	0
Legal settlement	2,038	0
Uncollectible receivable - related party	3,862	0
Loss on extinguishment of debt - related party	2,142	0
Fair value of common stock issued	0	56
Other non-cash expenses	127	15
Changes in operating assets and liabilities:	'	'
Accounts receivable	212	-517
Inventories	-1,124	1,225
Restricted cash	0	-159
Prepaid expenses and other current assets	12	61
Accounts payable and accrued liabilities	2,115	1,263
Accrued interest on note payable to related party	252	0
Deferred revenue	80	0
Income taxes payable	114	-131
Net cash (used in) provided by operating activities	-2,607	3,500
Cash flows from investing activities:	'	'
Purchases of long-lived assets	-1,183	-672
Proceeds from disposal of long-lived assets	18	0
Net cash used in investing activities	-1,165	-672
Cash flows from financing activities:	'	'
Net proceeds from line of credit	1,600	0
Principal payments on notes payable	-2,621	-2,413
Principal payments on related party note payable	0	-250
Payments to reacquire and retire common stock	0	-139
Payments of debt issuance and deferred financing costs	-163	-309
Proceeds received from issuance of convertible preferred stock	4,000	0
Payment of preferred stock issuance costs	-647	0
Payment in connection with legal settlement agreement	-275	0
Principal payments on capital lease obligations	-14	-37
Net cash provided by (used in) financing activities	1,880	-3,148
Effect of exchange rate changes on cash	62	64
Net decrease in cash	-1,830	-256
Cash, beginning of period	2,695	2,951
Cash, end of period	$865	$2,695

Background_And_Description_of_

Background And Description of Business	12 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
BACKGROUND AND DESCRIPTION OF BUSINESS	'
		1	BACKGROUND AND DESCRIPTION OF BUSINESS
	These consolidated financial statements and footnotes include the financial position and operations of Cyalume Technologies Holdings, Inc. (“Cyalume” or the “Company”), a holding company that is the sole shareholder of Cyalume Technologies, Inc. (“CTI”) and of Cyalume Specialty Products, Inc. (“CSP”). CTI is the sole shareholder of Cyalume Technologies, SAS (“CTSAS”), Cyalume Realty, Inc. (“CRI”) and Combat Training Solutions, Inc. (“CTS”). All significant intercompany accounts and transactions have been eliminated in consolidation.
	The Company’s primary focus is providing tactical and training solutions to the military of the U.S. and other countries through both products and services.
	CTI and CTSAS manufacture and sell chemiluminescent products and reflective and photoluminescent materials to military, ammunition, commercial and public safety markets. CTSAS is located in France and represents us in certain international markets, primarily Europe and the Middle East. CTI sells to customers in all other geographic markets. CTI’s and CTSAS’ business operations constitute the majority, based on revenues and assets, of our consolidated business operations.
	CSP manufactures and sells specialty chemical products to the defense, pharmaceutical, cosmetic and other markets. CSP’s operations are located in Bound Brook, New Jersey.
	CRI previously owned land located in Colorado Springs, Colorado. The land was transferred in connection with a 2013 legal settlement (see Note 18).
	CTS provides its customers with battlefield effects simulation products while its services include planning and implementing tactical training exercises simulating real-world experiences. These products allow military and law enforcement professionals to maintain operational readiness through safe, live training and hands-on situational exercises.
	Our business is managed and financial results are reported as one segment. The CEO, who is the chief operating decision maker, focuses on consolidated results to make strategic and tactical decisions. Our one operating segment consists of four reporting units: Chemical Light (the operations of CTI and CTSAS), Training (the operations of CTS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.).
	The Company’s consolidated financial statements have been prepared assuming the Company will continue as a going concern. For the years ended December 31, 2013 and 2012, the Company had net losses of approximately $15.7 million and $50.2 million, respectively, and used approximately $2.6 million of cash in its operations for the year ended December 31, 2013. The Company generated approximately $3.5 million in cash flow from operating activities for the year ended December 31, 2012. As of December 31, 2013 and 2012, the Company had an accumulated deficit of approximately $95.9 million and $80.2 million, respectively, and total stockholders’ equity of $6.5 million and $25.3 million, respectively. The Company’s unrestricted cash balance was approximately $0.9 million at December 31, 2013.
	Due to uncertainty about the Company’s ability to meet its current operating expenses and current obligations, in their report on our annual financial statements for the year ended December 31, 2013, the Company’s independent registered public accounting firm included an explanatory paragraph regarding the Company’s ability to continue as a going concern. The Company’s current liabilities include approximately $4.0 million relating to a contingent legal obligation (see Note 18).
	In light of the Company’s results of operations, management has been evaluating various possibilities including but not limited to refinancing or restructuring the Company’s debt, reducing or eliminating operating expenses, and raising additional capital through the issuance of common or preferred stock or securities convertible into common stock. These possibilities, to the extent available, may be on terms that result in significant dilution to the Company’s existing stockholders, may reduce the value of the stockholders’ investment in the Company or may impact the Company’s stock price.
	There can be no assurances that the Company will be successful in raising adequate additional financial support. If not, the Company will be required to reduce operations. The Company’s consolidated financial statements do not include any adjustments relating to the recoverability of assets and classification of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
SIGNIFICANT ACCOUNTING POLICIES	'
		2	SIGNIFICANT ACCOUNTING POLICIES
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.
	Foreign Operations
	The accounting records of our France-based subsidiary CTSAS are maintained in Euros, their local and functional currency. For consolidation, revenue and expense transactions are translated to U.S. dollars using the average exchange rate of the month in which the transaction took place. Assets and liabilities are translated to U.S. dollars using the exchange rate in effect as of the balance sheet date. Equity transactions are translated to U.S. dollars using the exchange rate in effect as of the date of the equity transaction. Translation gains and losses are reported as a component of accumulated other comprehensive income within stockholders’ equity. Gains and losses resulting from transactions which are denominated in other than the functional currency are reported as other income or loss in the statement of comprehensive income (loss) in the period the gain or loss occurred.
	Comprehensive Loss
	Comprehensive loss accounts for changes in stockholders’ equity resulting from non-stockholder sources. All transactions that would cause comprehensive loss to differ from net loss have been recorded and disclosed and relate to (i) the translation of the accounting records of our France-based subsidiary CTSAS and (ii) the effective portion of activities designated as hedges for hedge accounting purposes.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates are used when accounting for certain items such as reserves for inventory, accounts receivable and deferred tax assets; assessing the carrying value of intangible assets including goodwill; determining the useful lives of property, plant and equipment and intangible assets; determining asset retirement obligations; and determining the fair value of contingent consideration. Estimates are based on historical experience, where applicable, and assumptions that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved with estimates, actual results may differ.
	Accounts Receivable
	Accounts receivable are recorded at the aggregate unpaid amount less any allowance for doubtful accounts. The allowance is based on historical bad debt experience and the specific identification of accounts deemed uncollectible. An account receivable’s delinquency status is determined based on its contractual terms. Interest is not charged on outstanding balances. Accounts are written off only when all methods of recovery have been exhausted. Credit risk is controlled through initial credit evaluations and approvals, credit limits, and monitoring procedures. Ongoing credit evaluations of customers are performed but do not require collateral to secure accounts receivable.
	Inventories
	Inventories are stated at the lower of cost (on a first-in first-out (“FIFO”) method) or net realizable value. The cost of inventory consists of raw material content, labor costs to produce the inventory and overhead costs incurred during production of the inventory. The Company periodically reviews the realizability of inventory. Provisions are recorded for potential obsolescence which requires management’s judgment. Conditions impacting the realizability of inventory could cause actual write-offs to be materially different than provisions for obsolescence.
	Property, Plant and Equipment
	Property, plant and equipment are stated at cost. Depreciation is computed under the straight-line method over the estimated useful lives of four to eight years for equipment and 30 years for buildings and improvements.
	Property, plant and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Such reviews are based on a comparison of the asset’s undiscounted cash flows to the recorded carrying value for the asset. If the asset’s recorded carrying value exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset, the asset’s carrying value is written-down to its estimated fair value. To estimate that fair value, the Company uses the most appropriate valuation technique for the circumstances and for which sufficient data is available. Impairment charges, if any, are recorded in the period in which the impairment is determined. In the event of an impairment charge, the identifiable assets’ post-impairment carrying value will continue to be amortized or depreciated over their useful lives and be reviewed periodically for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.
	Goodwill
	Goodwill is deemed to have an indefinite life and accordingly, is not subject to amortization. Goodwill is subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon its estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.
	Intangible Assets
	Intangible assets include developed technologies and patents, customer relationships, non-compete agreements, trademarks and trade names, all of which are amortized over their estimated useful lives. The carrying amounts of amortizing intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that those carrying amounts may not be recoverable and are also reviewed for impairment annually as of August 31.
	Costs incurred to register new patents or defend existing patents are capitalized, while costs to renew or extend the term of intangible assets are expensed when incurred. Costs incurred with third parties that are related to internally developing or successfully defending an intangible asset are capitalized as part of the intangible asset developed or defended and amortized over that asset’s remaining useful life. Such costs with third parties related to patent or trademark applications that are ultimately rejected by the relevant government authority are expensed upon rejection. The useful lives used for amortization of intangible assets are as follows:
			Useful lives
	Patents and developed technologies			-1
	Purchased customer relationships			9 – 13 years
	Trademarks and trade names			-2
	Non-compete agreements			5 years
		-1	Each patent has its own legal expiration date and, therefore, its own useful life. Generally, our patents’ legal lives begin when the related patent application is filed with the relevant government authority and ends 20 years thereafter. Amortization on patent costs begins when the relevant government authority approves the related patent. Patents that have been recorded as of December 31, 2013 are expected to expire by 2033.
		-2	Trademarks and trade names of CTI are deemed to have a useful life of 15 years. CTI’s trademarks and trade names are subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon their estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.
	Debt Issuance and Deferred Financing Costs
	Costs paid to lenders to obtain financing are presented as discounts on the related debt and are amortized to interest expense over the term of the related financing, using the effective interest method (unless the financing is a line of credit, in which case the straight-line method is used). Such costs paid to third parties are presented as assets and are amortized to interest expense in the same manner as costs paid to lenders.
	Derivatives
	Derivatives are recorded at their fair value as of the balance sheet date. If a derivative qualifies for “hedge accounting” under U.S. GAAP and has been designated as a hedge by us, then the “effectively hedged” portion is recorded, as defined by U.S. GAAP, of changes in such derivatives’ fair value in accumulated other comprehensive loss, which is a component of our stockholders’ equity. The Company records (i) ineffectively hedged portions of such changes in fair value or (ii) changes in the fair value of derivatives not designated as a hedge in our consolidated statement of comprehensive income (loss) in the period the change occurred. On the consolidated statement of cash flows, cash flows from derivative instruments accounted for as cash flow hedges are classified in the same category as the cash flows from the items being hedged.
	Warrants Liability
	The Company uses fair values as determined by significant unobservable inputs. These estimated values are significant inputs into the Monte Carlo simulation method and the Black Scholes pricing model used to calculate the estimated fair value of common warrants and preferred warrants potentially settleable in cash, which are recorded as warrants liability. The estimated fair value of the common warrants and the preferred warrants are determined at each balance sheet date and the change in the estimated fair value of the warrants is reflected within the Company’s statements of comprehensive loss.
	Revenue Recognition
	Revenue from the sale of products or the providing of services is recognized when the earnings process is complete, the amount of recognizable revenue can be determined, the risks and rewards of ownership have transferred to the customer and collectability is reasonably assured. Depending on the terms of the individual sales arrangement with our customer, product sales are recognized at either the shipping point or upon receipt by the customer. Costs and related expenses to manufacture the products are recorded as costs of goods sold when the related revenue is recognized. Additionally, if the right of return is granted to the buyer in a product sale, revenue is deferred until enough historical customer data is available to reasonably estimate returns and related costs.
	Two significant contracts provide for the sale of indefinite quantities of products at fixed per unit prices, subject to adjustment for certain economic factors. Revenue under these contracts is recognized when products ordered under the contracts are received by the customer. Whenever costs change, the pricing under these contracts is reviewed to determine whether they require the sale of products at a loss. To date, there are no loss contracts which would require the accrual of future losses in the current financial statements.
	Research and development services are provided for customers for which the Company earns payments that are contingent upon achieving a specific result (“milestones”). Upon achieving such milestones, revenue is recognized provided that the payment is (i) related to past performance, (ii) reasonable relative to all of the deliverables and payment terms within the arrangement with our customer, and (iii) nonrefundable. In 2013 and 2012, all of such payments received met these criteria.
	Taxes Collected from Customers
	Sales taxes collected from customers are not considered revenue and are included in accounts payable and accrued expenses until remitted to the taxing authorities.
	Shipping and Handling Costs
	Outbound shipping and handling costs are included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income (loss). These costs were approximately $423,000 and $500,000 for the years ended December 31, 2013 and 2012, respectively.
	Advertising Costs
	Advertising costs are expensed as incurred and are included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income (loss). Advertising expense was $215,000 and $135,000 for the years ended December 31, 2013 and 2012, respectively.
	Stock-Based Compensation
	Stock-based compensation is incurred related to awards of common stock, restricted common stock and options to employees and non-employees. Those awards are measured at their fair value on the date the award is granted and are recognized in our consolidated financial statements over the period the grantee is required to provide services in exchange for the award. When recognized as an expense, the fair value of the award, less estimated forfeitures, is recognized on a straight-line basis over the award service period; if there is no such service period, then the entire fair value of the award is recognized as expense on the grant date.
	Income Taxes
	Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are recognized when, based upon available evidence, realization of the assets is more likely than not.
	In assessing the realization of long-term deferred income tax assets, it is considered whether it is more likely than not that the deferred income tax assets will be realized. The realization of deferred income tax assets depends upon future taxable income in years before net operating loss carryforwards expire. The recoverability of deferred income tax assets is evaluated on a quarterly basis. If the Company determines that it is more likely than not that deferred income tax assets will not be recovered, a valuation allowance is established against some or all deferred income tax assets.
	When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceeds the amount measured as described above, if such a position existed, is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. There were no such positions as of December 31, 2013 or 2012.
	Interest on tax deficiencies is classified as interest expense and income tax penalties are classified as other expense.
	In February 2012, an IRS audit was completed of the Company’s tax returns for the years 2008 and 2009. There were no adjustments to those tax returns. Tax returns filed for the fiscal years 2010, 2011, and 2012 are still open for audit.
	Net Loss per Common Share
	Basic loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding. Diluted loss per common share is computed by dividing net loss by the weighted average number of common shares and dilutive potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible notes using the “if-converted” method.
			Year Ended December 31,
			2013		2012
	Basic and diluted:
	Net loss (in thousands)		$	-15,653	$	-50,218
	Accrued dividend and deemed dividend		$	-5,608	$	0
	Weighted average shares			20,714,531		18,205,586
	Loss available to common stockholders for basic and diluted loss per common share (in thousands)			-21,261		-50,218
	Basic and diluted loss per common share		$	-1.03	$	-2.76
	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented:
		Year Ended December 31,
		2013		2012
Options and warrants			3,012,186		1,585,833
Restricted stock awards			34,266		75,292
Convertible notes payable			2,666,667		2,666,667
Fair Value
Under U.S. GAAP, the Company is required to record certain financial assets and liabilities at fair value and may choose to record other financial assets and financial liabilities at fair value as well. Also under U.S. GAAP, the Company is required to record nonfinancial assets and liabilities at fair value due to events that may or may not recur in the future, such as an impairment event. When required to record such assets and liabilities at fair value, that fair value is estimated using an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. That fair value is determined based on significant inputs contained in a fair value hierarchy as follows:
	Level 1	Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.
	Level 2	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
	Level 3	Unobservable inputs for the asset or liability.
The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
There are three general valuation techniques that may be used to measure fair value, as described below:
Market Approach	Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.
Cost Approach	Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
Income Approach	Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (includes present value techniques and option-pricing models). Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.
Recent Accounting Pronouncements
The following are recent accounting pronouncements that have affected our consolidated financial statements or may affect them in the future.
In October 2012, the FASB issued Accounting Standards Update No. 2012-04, Technical Corrections and Improvements (“ASU 2012-04”), which updates a wide range of topics in the FASB Codification. ASU 2012-04 includes technical corrections and improvements to FASB Codification and conforming amendments related to fair value measurements. ASU 2012-04 was effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 did not have a material impact on our financial position or results of operations.
In July 2013, the FASB issued Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists (“ASU 2013-11”) to clarify that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carry-forward, a similar tax loss, or a tax credit carry-forward, with some allowed exceptions. ASU 2013-11 does not impose any new recurring disclosure requirements because it does not affect the recognition or measurement of uncertain tax positions. ASU 2013-11 is effective for fiscal years beginning after December 15, 2013. The Company believes the adoption of ASU 2013-11 will not have a material impact on our financial position or results of operations.

Impairment_Charges

Impairment Charges	12 Months Ended
	Dec. 31, 2013
Asset Impairment Charges [Abstract]	'
IMPAIRMENT CHARGES	'
		3	IMPAIRMENT CHARGES
	During 2013, CTS recorded a goodwill impairment loss of $168,000 and a loss on impairment of certain amortizable intangible assets of $875,000. During 2012, CTI recorded a $47.1 million loss on goodwill impairment, a $281,000 loss on impairment of certain amortizing intangible assets and a $273,000 loss on impairment of certain manufacturing equipment. See Note 7 for a summary of activity affecting goodwill during the years ending December 31, 2013 and 2012, respectively. The Chemical Light’s trade name intangible asset was not considered to be impaired as of August 31, 2013 or as of August 31, 2012. See Note 8 for a summary of activity affecting intangible assets during the years ending December 31, 2013 and 2012. See Note 23 for fair value information on these assets.
	During 2013, management conducted a review of tangible and intangible assets for impairment. Before assessing whether any of our reporting units’ goodwill was impaired, the Company first assessed whether any non-goodwill assets were impaired. This assessment determined that the CTS patent asset was impaired by approximately $174,000, CTS trademarks and trade names were impaired by approximately $17,000, CTS customer relationships intangibles were impaired by approximately $650,000 and CTS non-compete agreements were impaired by approximately $34,000. Therefore, the Company recorded $875,000 of an impairment loss on these CTS intangible assets during the second quarter of 2013.
	The “step 1” goodwill impairment assessment was performed by comparing the fair value of each reporting unit containing goodwill to those reporting units’ carrying values. The Chemical Light, Training, and Specialty Products reporting units have goodwill assets. Since there are no quoted market prices for our reporting units, the fair value of our reporting units were determined using a discounted present value
	technique utilizing each reporting unit’s forecasted after-tax cash flows. The “step 1” test determined that the carrying value of the CTS Training reporting unit exceeded its fair value, and, therefore, its goodwill needed to be tested further under what is commonly known as “step 2” of the goodwill impairment assessment. CTS did not pass the “step 1” test due to the inability to both gain traction with new products and services and attract new customers as initially planned when the reporting unit was acquired in December 2011.
	Under “step 2” of the goodwill impairment assessment, the implied fair value of CTS Training’s goodwill was compared with the carrying amount of that goodwill. If the carrying amount of the goodwill exceeds the implied fair value of that goodwill, that excess must be recognized as an impairment loss. The implied fair value of goodwill was determined in the same manner as the amount of goodwill recognized in a business combination. The excess of the fair value of the reporting unit over the amounts assigned to its assets and liabilities is the implied amount of the reporting unit’s goodwill. The Company identified several intangible assets that were valued during this process, including customer relationships, patents, trade names, non-compete agreements, and our workforce. The allocation process was performed only for purposes of goodwill impairment. The Company determined the fair value of these assets using various discounted cash flow-based methods that utilize assumptions such as the ability of these assets to generate future cash flows, present-value factors, income tax rates and customer attrition rates. The “step 1” calculated fair value of the CTS reporting unit was allocated to the CTS tangible and identifiable intangible assets of the CTS reporting unit at June 30, 2013 based upon the results of the “step 2” analysis, which included a full impairment to the CTS goodwill.
	During 2012, before conducting its annual goodwill impairment assessment, the Company first assessed whether any non-goodwill assets were impaired because it was considered that such assets might be impaired due to declines in the Company’s stock price at that time and industry conditions discussed later in this Note 4. This assessment determined that the CTS Training’s patent asset was impaired $172,000, the CTS Training’s trade name asset was impaired $29,000 and the CTS non-compete agreement asset was impaired $80,000. Therefore, the Company recorded a $281,000 impairment loss on these intangible assets during 2012. This assessment also determined that one piece of Chemical Light’s manufacturing equipment with a carrying value of $273,000 had no value. Since the Company did not foresee using this equipment in the future, a $273,000 impairment loss was recognized during 2012 as well.
	The Company then assessed qualitative factors to determine whether it is more likely than not that the fair values of our reporting units that contain goodwill are less than their carrying value. In addition to these intangible asset impairments, the Company identified two factors, adverse changes in our stock price and adverse changes in industry/market considerations, that led the Company to conclude that it was more likely than not that the fair value was less than the carrying value. Beginning in April 2012, the Company’s share price began steadily dropping and was at a closing price of $2.34 on August 31, 2012.
	Regarding industry conditions, during the past several years, based on the success of the Chemical Light’s 40mm training round purchased by the U.S. Marine Corps that uses the Company’s chemical light technology, the Company believed that the volume of this product would grow when adopted by the U.S. Army. The Company completed production requirements under the Marine Corps contract, which expired in 2012. It was learned in 2012 that the Marines Corps contract would not be extended. During the third quarter of 2012, the Company concluded that the U.S. Army would not be purchasing the product. Instead, it was understood that the U.S. military was planning for a new 40mm training round that should be produced around 2015, and that this new round would likely not be based on chemical light technology. While that could change, it was believed at that time that it was more likely than not that the new round would not employ the Company’s chemical light technology. Consequently, these factors led the Company to significantly reduce its long-term revenue growth projected for its ammunition sector. Since the ammunition sector had previously been expected to be the largest contributor to the Company’s total revenues, the forecasted reduction resulted in a significant decrease in projected cash flows.
	The Company then performed what is commonly known as “step 1” of the goodwill impairment assessment by comparing the fair value of each reporting unit containing goodwill to those reporting units’ carrying values. Only the Chemical Light, CTS Training, and CSP Specialty Products reporting units have goodwill assets. Since there are no quoted market prices for our reporting units, the fair value of the Company’s reporting units were determined using a discounted present value technique utilizing each reporting unit’s forecasted after-tax cash flows. The “step 1” test determined that the carrying values of the CTS Training and the Chemical Light reporting units exceeded their fair values and therefore their goodwill needed to be tested further under what is commonly known as “step 2” of the goodwill impairment assessment.
	Under “step 2” of the goodwill impairment assessment, the implied fair value of Chemical Light’s and Training’s goodwill was compared with the carrying amount of that goodwill. If the carrying amount of the goodwill exceeds the implied fair value of that goodwill, that excess must be recognized as an impairment loss. The implied fair value of goodwill was determined in the same manner as the amount of goodwill recognized in a business combination is determined. The excess of the fair value of each reporting unit over the amounts assigned to its assets and liabilities is the implied amount of the reporting unit’s goodwill. The Company identified several intangible assets that were valued during this process, including technology, customer relationships, trade names, non-compete agreements, and our workforce. The allocation process was performed only for purposes of goodwill impairment. The Company determined the fair value of these assets using various discounted cash flow-based methods that utilize assumptions such as the ability of these assets to generate future cash flows, present-value factors, income tax rates and customer attrition rates. During the year ended December 31, 2012, the Company recorded approximately $47.1 million relating to the impairment of goodwill and approximately $281,000 relating to the impairment of intangible assets.

Inventories

Inventories	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
INVENTORIES	'
	4	INVENTORIES
	Inventories, net consist of the following (all amounts in thousands):
			2013		2012
	Raw materials		$	6,535	$	6,255
	Work-in-process			2,185		1,530
	Finished goods			2,062		1,812
			$	10,782	$	9,597

Prepaid_Expenses_And_Other_Cur

Prepaid Expenses And Other Current Assets	12 Months Ended
	Dec. 31, 2013
Prepaid Expense and Other Assets, Current [Abstract]	'
PREPAID EXPENSES AND OTHER CURRENT ASSETS	'
		5	PREPAID EXPENSES AND OTHER CURRENT ASSETS
	Prepaid expenses and other current assets consist of the following (all amounts in thousands):
			2013		2012
	Value added taxes receivable		$	17	$	53
	Franchise taxes receivable			0		32
	Prepaid expenses			312		322
	Debt issuance costs, current portion			53		136
	Other			81		15
			$	463	$	558

Property_Plant_And_Equipment

Property, Plant And Equipment	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
PROPERTY, PLANT AND EQUIPMENT	'
		6	PROPERTY, PLANT AND EQUIPMENT
	Property, plant and equipment consist of the following (all amounts in thousands):
			2013		2012
	Land		$	1,285	$	1,904
	Building and improvements			3,332		3,256
	Machinery and equipment			8,300		7,905
	Leasehold improvements			266		0
	Furniture and fixtures			122		69
	Software			59		0
				13,364		13,134
	Less: accumulated depreciation and amortization			-5,363		-3,957
			$	8,001	$	9,177
	At December 31, 2013 and 2012, machinery and equipment includes approximately $77,000 of assets recorded under capital leases. Accumulated depreciation on those capital leases totaled approximately $20,000 and $9,000 as of December 31, 2013 and 2012, respectively. In 2013 and 2012, depreciation expense for those assets was $11,000 and $9,000, respectively.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2013
Goodwill, Impaired [Abstract]	'
GOODWILL	'
		7	GOODWILL
	Goodwill represents the excess of the cost of acquiring CTI and CTSAS in 2008 and CSP and CTS in 2011 over the net fair value assigned to the assets acquired and liabilities assumed in those acquisitions, net of adjustments and impairment losses. Changes in the carrying amount of goodwill consist of the following (all amounts in thousands):
				CTI/CTSAS						Total Consolidated
				Chemical Light		CTS Training	CPS			Goodwill
	Balance on December 31, 2011 (1)		$	51,244	$	1,107	$	2,978	$	55,329
	Impairment loss (see Notes 3 and 23)			-46,230		-858		0		-47,088
	Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets			0		-183		0		-183
	Finalization of the fair value determination of contingent consideration in the CTS acquisition (2)			0		166		0		166
	Finalization of the CTS acquisition-related deferred tax liability (2)			0		-64		0		-64
	Balance on December 31, 2012 (3)			5,014		168	$	2,978		8,160
	Impairment loss (see Notes 3 and 23)			0		-168		0		-168
	Balance on December 31, 2013 (4)		$	5,014	$	0	$	2,978	$	7,992
		-1	Gross amount of goodwill was approximately $67.8 million as of December 31, 2011. Accumulated impairment losses were $12.5 million as of December 31, 2011.
		-2	On December 22, 2011, CTI entered into a Stock Purchase Agreement (“SPA”) with CTS and the sole stockholder of CTS. A portion of the consideration paid to the sellers of CTS is contingent upon the financial performance of the acquired business during the combined calendar years 2012 and 2013. The initial accounting for that contingent consideration liability was not complete as of December 31, 2011 since the fair value determination of that liability had not yet been finalized. The finalization of this accounting during 2012 resulted in a $166,000 increase in both CTS’ goodwill asset and contingent consideration liability. Additionally, the initial accounting for the CTS acquisition-related deferred tax liability had not yet been finalized as of December 31, 2011. The finalization of this accounting during 2012 resulted in a $64,000 decrease in both CTS’s goodwill asset and deferred tax liability.
		-3	Gross amount of goodwill was approximately $67.7 million as of December 31, 2012. Accumulated impairment losses were approximately $59.5 million as of December 31, 2012.
		-4	Gross amount of goodwill was approximately $67.7 million as of December 31, 2013. Accumulated impairment losses were approximately $59.7 million as of December 31, 2013.

Other_Intangible_Assets

Other Intangible Assets	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
OTHER INTANGIBLE ASSETS	'
		8	OTHER INTANGIBLE ASSETS
	Intangible assets as of December 31, 2013 consist of the following (all amounts in thousands):
			Cost		Accumulated		Net Book Value
					Amortization
	Developed technologies, including patents (1)		$	13,853	$	5,720	$	8,133
	Trademarks and trade names			5,365		119		5,246
	Purchased customer relationships (2)			8,812		4,336		4,476
	Non-compete agreements (3)			160		75		85
	Website development costs			8		0		8
			$	28,198	$	10,250	$	17,948
		-1	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 were impaired by approximately $221,000 during 2013 (see Note 3 Impairment Charges) and the $17,000 of CTS patents remaining after the impairment is expected to be fully amortized in December 2021.
		-2	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Customer relationships obtained in the acquisition of CTS with a cost of $840,000 was impaired by approximately $780,000 (see Note 3 Impairment Charges) and the $60,000 of CTS customer relationships remaining after the impairment is expected to be fully amortized in December 2021.
		-3	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 was determined to be fully impaired in 2013 (see Note 3 Impairment Charges).
	In 2013 and 2012, some of these intangible assets were found to be impaired and their cost was reduced accordingly. See Note 3 and 24 for a discussion regarding these impairments.
	Intangible assets as of December 31, 2012 consist of the following (all amounts in thousands):
			Cost		Accumulated		Net Book Value
					Amortization
	Developed technologies, including patents (1)		$	13,730	$	4,755	$	8,975
	Trademarks and trade names (2)			5,401		37		5,364
	Purchased customer relationships (3)			9,507		3,811		5,696
	Non-compete agreements (4)			220		65		155
			$	28,858	$	8,668	$	20,190
		-1	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Also includes patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 (see Note 3 Impairment Charges).
		-2	Includes a trade name obtained in the acquisition of CTS with an initial cost of $90,000 (see Note 3 Impairment Charges).
		-3	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Also includes customer relationships obtained in the acquisition of CTS with a cost of $840,000 (see Note 3 Impairment Charges).
		-4	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Also includes non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 (see Note 3 Impairment Charges).
	Trademarks can be renewed without substantial cost. If trademark and trade names are not renewed, then expected future cash flows associated with trademarks and trade names could be adversely affected.
	Amortization of intangible assets was $1.8 million and $1.9 million for the years ended December 31, 2013 and 2012, respectively.
	During 2013, the Company capitalized $27,000 and $342,000 of costs paid to third parties to create or defend trademarks and patents, respectively. During 2012, the Company capitalized $3,000 and $292,000 of costs paid to third parties to create or defend trademarks and patents, respectively. The Company expects the patent-related costs to be amortized over approximately 20 years.
	The Company does not consider any intangible assets to have residual value.
	The future amortization expense relating to finite-lived intangible assets for the next five years and beyond is estimated at December 31, 2013 to be (all amounts in thousands):
	Year Ending December 31,
	2014		$	1,970
	2015			1,970
	2016			1,959
	2017			1,927
	2018			1,889
	Thereafter			7,011
			$	16,726

Debt_Issuance_Costs

Debt Issuance Costs	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
DEBT ISSUANCE COSTS	'
	9	DEBT ISSUANCE COSTS
	Debt issuance costs consist of unamortized costs paid to third parties to obtain senior debt, a line of credit, convertible notes and an amended related party note that will be amortized to interest expense using the effective interest method through 2015 and 2016. Amortization of capitalized debt issuance costs was approximately $113,000 and $119,000 for the years ended December 31, 2013 and 2012, respectively.
	The future amortization expense relating to current and noncurrent capitalized debt issuance costs is approximately $86,000 and will be amortized to interest expense using the effective interest method through 2016.

Accrued_Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2013
Payables and Accruals [Abstract]	'
ACCRUED EXPENSES	'
		10	ACCRUED EXPENSES
	Accrued expenses consist of the following (all amounts in thousands):
			2013		2012
	Payroll-related (1)		$	1,145	$	1,817
	Interest			331		143
	Professional fees			26		178
	Related party payable – Selway Capital, LLC (2)			158		32
	Other			399		413
			$	2,059	$	2,583
		-1	Accrued payroll-related costs as of December 31, 2013 include approximately $534,000 of accrued severance costs. Accrued payroll-related costs as of December 31, 2012 include approximately $296,000 of accrued severance costs.
		-2	See Note 18 for a description of the agreement with Selway Capital, LLC.

Lines_Of_Credit

Lines Of Credit	12 Months Ended
	Dec. 31, 2013
Line Of Credit Facility [Abstract]	'
LINES OF CREDIT	'
		11	LINES OF CREDIT
	The Company has a line of credit with a maximum borrowing capacity of $5.0 million with TD Bank N.A. (“TD Bank”). The amount which may be borrowed from this line of credit is dependent mainly on accounts receivable and inventory balances. Interest is payable monthly and is determined based on (i) the Prime Rate, plus 3%. The line of credit’s interest rate at December 31, 2013 was 6.25%. The line of credit expires on December 19, 2015. This line of credit is subject to (i) the same restrictive covenants and (ii) the same collateral and guarantees as the senior debt Term Loan and the senior debt Real Estate Loan (see Note 12). At December 31, 2013, $1.6 million was outstanding on this line of credit and borrowing availability was approximately $840,000 at December 31, 2013. At December 31, 2012, there were no outstanding borrowings on this line of credit.
	CTSAS has lines of credit with a combined maximum borrowing capacity of €800,000 ($1.1 million as of December 31, 2013), under which there were no outstanding borrowings at December 31, 2013 or 2012. The lines’ interest rates are variable, based on the Euro Overnight Index Average and the 3-month Euro Interbank Offered Rate. The lines are collateralized by primarily CTSAS accounts receivable. The lines have indefinite termination dates, but can be renegotiated periodically.

Notes_Payable

Notes Payable	12 Months Ended
	Dec. 31, 2013
Notes Payable [Abstract]	'
NOTES PAYABLE	'
	12	NOTES PAYABLE
	Outstanding notes payable consist of (all amounts in thousands):
			2013		2012
	Senior Debt - Term Loan		$	6,023	$	8,519
	Senior Debt - Real Estate Loan			1,679		1,804
	Subordinated Term Loan			8,659		8,500
	Promissory Note Payable			1,075		0
	Total			17,436		18,823
	Less: Unamortized debt discount			-542		-695
	Less: Current portion of notes payable, including current portion of unamortized debt discount			-1,925		-9,734
	Notes payable, net of current portion		$	14,969	$	8,394
	Debt issuance costs are amortized to interest expense using the effective interest method over the life of the loan.
	Senior Debt
	CTI has two loans payable to TD Bank, NA (“TD Bank”); a Term Loan and a Real Estate Loan, that were originally entered into on December 19, 2008, and which were amended twice during 2012 to modify certain financial and non-financial covenants required by these loans. The Fourth Amendment to the Amended and Restated Revolving Credit and Term Loan Agreement (the “Senior Amendment”) was entered into on November 19, 2013.
	The Term Loan is payable in monthly principal installments of $148,000 along with monthly interest payments as described below, plus a one-time principal payment of approximately $2.5 million due at maturity in December 2015.
	The Company compared the present value of the cash flows of the Term Loan and the Real Estate Loan, before the Senior Amendment on November 19, 2013, with the present value of the cash flows pursuant to the Senior Amendment. The Company determined that the cash flow effect on a present value basis was less than 10 percent on the date of the Senior Amendment. Therefore, for accounting purposes, the Senior Amendment was treated as a modification of the Term Loan and the Real Estate Loan and approximately $90,000 was expensed relating to debt modification costs.
	Interest payments on 60% of the Term Loan’s principal balance were previously hedged using a pay-fixed, receive-variable interest rate swap to reduce exposure to changes in cash payments caused by changes in interest rates on the Term Loan. See Note 16 for details on the interest rate swap. Interest on the 60% interest rate-swapped portion of the Term Loan was payable monthly and determined based on 1-month LIBOR, plus a margin percentage that is based on financial performance. The total interest rate on the swapped portion of the Term Loan was changed from 6.53% to 6.25% on December 19, 2013 and was 6.53% at December 31, 2012. Interest on the remaining 40% of the Term Loan was also payable monthly and was determined based on 1-month LIBOR (subject to a 2% interest rate floor) plus a margin percentage that was based on financial performance. At December 31, 2013 and 2012, the total interest rate on the portion of the Term Loan that was not subject to an interest rate hedging relationship was at 6.25% and 6.0%, respectively. The Term Loan is collateralized by all of the assets of CTI (except CTI’s equity interests in CTSAS, of which only 65% is collateral of the Term Loan) and is guaranteed by Cyalume. The Term Loan requires various restrictive financial and nonfinancial covenants, such as a maximum leverage ratio, debt service coverage ratio and limitations on capital expenditures and dividends, with which we are in compliance as of December 31, 2013.
	The Real Estate Loan is payable in monthly principal installments of approximately $10,000, along with monthly interest payments as described below, plus a one-time principal payment of $1.4 million due at maturity in December 2015.
	Interest payments on the Real Estate Loan principal balance were hedged using a pay-fixed, receive-variable interest rate swap to reduce exposure to changes in cash payments caused by changes in interest rates on the Real Estate Loan. See Note 16 for details on the interest rate swap. Interest is payable monthly and is determined based on 1-month LIBOR plus a margin percentage that was based on financial performance. The Real Estate Loan’s total interest rate was changed from 6.42% to 6.25% on December 19, 2013 and was 6.42% at December 31, 2012. The Real Estate Loan is secured by a mortgage of the real property (land and building) located in West Springfield, MA, and is guaranteed by Cyalume. The Real Estate Loan requires various restrictive financial and nonfinancial covenants, such as a maximum leverage ratio, debt service coverage ratio and limitations on capital expenditures and dividends, with which the Company is in compliance with as of December 31, 2013.
	The TD Bank line of credit (see Note 11), the Term Loan and the Real Estate Loan are senior in payment priority to all other notes payable and lines of credit.
	Subordinated Term Loan
	On July 29, 2010 the Subordinated Term Loan of $8.5 million was issued to Granite Creek Partners Agent, LLC (“Granite Creek”) and on November 19, 2013, the Company entered into a Fourth Amendment to the Subordinated Term Loan (the “Subordinated Amendment”) which extended the maturity date to June 30, 2016. Pursuant to the Subordinated Amendment, interest is payable in kind through December 19, 2015 and then payable monthly in cash through the June 30, 2016 maturity date. Interest is payable monthly at a rate of 11% per annum. No principal payments are required until maturity. The Company has the right to prepay the loan in whole or in part at any time without penalty in the event that the TD Bank Senior Debt is repaid. The Subordinated Term Loan ranks junior to all debt held by TD Bank, N.A. but senior to all other remaining long-term debt including existing and future subordinated debt. The Subordinated Term Loan is convertible at any time by Granite Creek into 2,666,667 shares of common stock at a conversion price of approximately $3.19 per share. No portion of the Subordinated Term Loan has been converted to our common stock. The Company’s common stock’s closing market price on December 31, 2013 was $0.69 per share; therefore the loan’s if-converted value of approximately $1.8 million is less than the unpaid principal balance by $6.8 million as of December 31, 2013. The Company previously determined that the convertible notes’ conversion feature was not a beneficial conversion feature under U.S. GAAP.
	The Company compared the present value of the cash flows of the Subordinated Term Loan, before the Subordinated Amendment on November 19, 2013, with the present value of the cash flows pursuant to the Subordinated Amendment. The Company determined that the cash flow effect on a present value basis was less than 10 percent on the date of the Subordinated Amendment. Therefore, for accounting purposes, the Subordinated Amendment was treated as a modification of the Subordinated Term Loan.
	Simultaneous with the issuance of the Subordinated Term Loan during 2010, the Company issued warrants to repay certain costs of obtaining the convertible notes. These warrants allowed the holder to purchase 160,000 shares of common stock at $1.50 per share through July 19, 2018. A portion of the $8.5 million gross proceeds from the issuance of the loan was allocated to the warrants based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds so allocated to the warrants ($207,000) was recorded as a debt discount and an increase to additional paid-in capital on our consolidated balance sheet. The warrant’s fair value was increased by $94,000 in 2012 due to (i) a decrease in the exercise price of the warrants and (ii) an extension of the term of the warrant. The warrants were amended again during 2013 in connection with the Senior Amendment described above. An additional amount of approximately $241,000 was added to debt discount and warrant liability during 2013 relating to (i) another decrease in the exercise price of the warrants to $0.01, (ii) an extension of the term of the warrants, and (iii) an increase to the number of shares of common stock that may be purchased upon exercise of the warrants to 455,514 shares of common stock that may be purchased. The debt discount is being amortized to interest expense using the effective interest method over the life of the convertible notes which have a maturity date of June 30, 2016. As a result of the amendment to the warrants, the warrants are no longer indexed to the Company’s stock, are considered a derivative and therefore, are being accounted for as a liability.
	The carrying value of the Subordinated Term Loan is as follows (all amounts in thousands):
			2013		2012
	Principal amount of loan		$	8,659	$	8,500
	Less: unamortized debt discount			-424		-622
			$	8,235	$	7,878
	Interest costs for the Subordinated Term Loan are as follows (all amounts in thousands):
			2013		2012
	Contractual interest coupon rate		$	949	$	951
	Amortization of related debt discount and debt issuance costs			486		308
	Total interest expense recognized		$	1,435	$	1,259
	The effective interest rate on the Subordinated Term loan was approximately 17% prior to the Subordinated Amendment, at which time the effective interest rate on the Subordinated Term loan became approximately 13%.
	Promissory Note Payable
	On November 19, 2013, the Company entered into a legal settlement agreement (see Note 18). The executed settlement agreement calls for the Company to make a series of payments over five years to Antonio Colon in the amount of $215,000 annually, for a total of $1,075,000 pursuant to the Promissory Note executed on November 19, 2013 (the “Promissory Note”). This Promissory Note bears interest at a rate of 2% annually and requires principal and interest payments each May and November. The Promissory Note has a maturity date of October 15, 2018.
	Future Minimum Payments
	As of December 31, 2013, future minimum payments due for notes payable (excluding the related party Amended JFC Note as discussed in Note 13) for each of the five succeeding years and beyond are as follows (all amounts in thousands):
	Year Ending December 31,
	2014		$	2,116
	2015			6,016
	2016			8,874
	2017			215
	2018			215
	Thereafter			0
			$	17,436
	Amortization of the debt discount was approximately $520,000 and $368,000 for the years ended December 31, 2013 and 2012, respectively.

Related_Party_Transaction

Related Party Transaction	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTION	'
		13	RELATED PARTY TRANSACTIONS
	Financing Arrangements with Related Parties
	In December 2012, the Company entered into a $2,100,000 unsecured promissory note with JFC Technologies, LLC (“JFC”), an entity controlled by an employee of CSP who is an owner of a significant amount of the Company’s common shares and is a board member. On November 19, 2013, the unsecured promissory note was amended (the “Amended JFC Note”). Pursuant to the Amended JFC Note, interest accrues on the principal amount at the rate of 12% per annum, retroactive to the date of the original note. The entire principal amount and all accrued interest under the Amended JFC Note is due on the maturity date of December 31, 2016, or upon the refinancing of the Company’s existing indebtedness (subject to the availability of at least $5,000,000 in available credit after such repayment). Pursuant to the Amended JFC Note, up to $1.0 million of the principal amount is convertible, at the option of JFC, into the number of shares of Series A Preferred Stock equal to the portion of the principal amount being converted divided by the conversion price of $32.50 per share (subject to adjustment based on certain changes in capitalization affecting the Series A Preferred Stock). In addition, upon conversion of the first $499,980 of Amended JFC Note principal, JFC would receive: (1) warrants to purchase for each $6.50 of principal amount converted, ten shares of the Company’s common stock, and (2) warrants to purchase for each $32.50 of principal amount converted, one share of Series A Preferred Stock. For the avoidance of doubt, JFC shall not be entitled to receive any warrants upon conversion of any portion of the principal amount in excess of $499,980 in the aggregate.
	In connection with the Amended JFC Note, the Company recorded a loss on the extinguishment of the original JFC Note of approximately $2.1 million as included within “Loss on extinguishment of debt – related party” within the accompanying consolidated statements of comprehensive loss.
	On November 19, 2013, the Company also issued a warrant to JFC to purchase up to 73,009 shares of the Company’s common stock. These warrants have an exercise price of $0.01 and expire on November 19, 2023. The fair value of this warrant was calculated using the Black-Scholes pricing model and approximately $54,000 is included within “Warrants liability” within the accompanying consolidated balance sheet as of December 31, 2013. Since the warrant is not indexed to the Company’s stock, it is considered a derivative and therefore, is being accounted for as a liability.
	Agreement with Board Member
	On October 1, 2009, the Company entered into an agreement with Selway Capital, LLC (“Selway”) that provides for services to be performed by Selway on our behalf. The agreement stipulates that these services would be performed by Yaron Eitan, an employee of Selway and a member of our Board of Directors, with assistance, as needed, from other employees of Selway. See Note 18, Commitments and Contingencies, for a description of the Selway agreement.
	Other Related Party Transactions
	CSP leases property in Bound Brook, New Jersey, from Brook Industrial Park, LLC, an entity that is controlled by an employee of CSP who is also an owner of a significant amount of our common shares and is one of our board members. See Note 18 for a description of this lease. This same related party and his wife collectively own 50% of China Development Group LLC. CSP previously engaged China Development Group LLC to source a pharmaceutical product sold by CSP, and paid commissions to China Development Group LLC during 2012 in compensation for such services. There were no commissions paid by CSP to China Development Group LLC in 2013. The amount of such commissions paid to China Development Group LLC in 2012 was approximately $310,000.
	Pursuant to an Amendment Agreement executed during December 2012, the Company is required to issue 350,000 shares of the Company’s common stock to JFC since the Company’s December 2013 common stock closing price was less than $1.75. The Company’s closing price on December 31, 2013 was $0.69 and therefore, the Company has recorded $242,000 within other current liabilities within the accompanying consolidated balance sheets as of December 31, 2013 and the shares were issued to JFC on January 31, 2014. The Company assessed the fair value as of December 31, 2012 of this potential obligation to issue additional shares at that time. The fair value was not material as of December 31, 2012 and therefore, no obligation was recorded at December 31, 2012.

Capital_Lease_Obligations

Capital Lease Obligations	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
CAPITAL LEASE OBLIGATIONS	'
		14	CAPITAL LEASE OBLIGATIONS
	As of December 31, 2013, future minimum lease payments under capital leases together with the present value of the net minimum lease payments were as follows (all amounts in thousands):
	Year Ending December 31,
	2014		$	17
	2015			7
	2016			0
	2017			0
	2018			0
	Thereafter			0
	Total minimum lease payments			24
	Less: amount representing interest			-2
	Present value of net minimum lease payments		$	22

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
		15	INCOME TAXES
	The components of income (loss) before income taxes are as follows:
			Year Ended December 31,
			2013		2012
	Domestic		$	-18,866	$	-54,153
	Foreign			175		966
			$	-18,691	$	-53,187
	Benefit from income taxes consisted of the following (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Current:
	Federal		$	0	$	0
	State			160		0
	Foreign			130		388
	Deferred:
	Federal			-2,678		-2,556
	State			-595		-738
	Foreign			-55		-63
	Benefit from income taxes		$	-3,038	$	-2,969
	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. The primary sources of these differences relate to the carrying value of identified intangible assets, inventories, fixed assets, certain accruals and reserves.
	Deferred income tax assets and liabilities consist of the following (all amounts in thousands):
			December 31, 2013				December 31, 2012
			Current		Non-current		Current		Non-current
	Deferred tax assets:
	Federal		$	6,329	$	7,230	$	1,390	$	8,256
	State			886		868		563		786
	Foreign			34		20		36		16
	Less: valuation allowance			-2,747		-3,175		-689		-3,185
				4,502		4,943		1,300		5,873
	Deferred tax liabilities:
	Federal			-477		-6,615		-469		-7,311
	State			-124		-1,697		-122		-1,886
	Foreign			-54		-478		-57		-538
				-655		-8,790		-648		-9,735
	Deferred tax assets (liabilities)		$	3,847	$	-3,847	$	652	$	-3,862
	Principal components of our net asset representing deferred income tax balances are as follows (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Intangible assets		$	-3,778	$	-3,408
	Property, plant and equipment			-740		-752
	U.S. loss carryforwards and tax credits, net (1)			8974		4,703
	Subsidiary income (2)			-1,671		-1,459
	Stock-based compensation expense			968		725
	Reserves, accruals and other			1,292		805
	Change in warrants fair value			877		0
	Valuation allowance			-5,922		-3,874
	Interest rate swaps			0		50
			$	0	$	-3,210
		-1	The Company had federal net operating loss carryforwards amounting to approximately $13.3 million and $2.0 million at December 31, 2013 and 2012, respectively. The net operating loss carryforward at December 31, 2013 expires in fiscal years 2025 through 2033. Internal Revenue Code Section 382 limits utilization of these losses to $3.2 million per year. It is possible that future changes in ownership could result in changes to the amounts allowed by IRC Section 382. State net operating loss carryforwards amounted to approximately $2.0 million and $1.0 million as of December 31, 2013 and 2012, respectively.
		-2	A deferred tax liability has been recorded for income taxes which may become payable upon distribution of earnings of CTSAS, our French subsidiary. The estimated amount of tax that might be payable with regard to any distribution for foreign subsidiary earnings is reported net of foreign taxes paid, which are creditable against our domestic tax liability. We do not permanently reinvest our foreign subsidiary’s earnings. The Company continually evaluates our assertion; if our foreign business needs change, so may our assertion.
	Income taxes computed using the federal statutory income tax rate differs from our effective tax rate primarily due to the following (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Provision for federal income taxes expected at 34% statutory rate		$	-6,355	$	-18,083
	Increase (reduction) resulting from:
	Tax on global activities			2		38
	State income taxes, less federal income tax benefit			-287		-518
	Exempt interest			728		0
	Change in valuation allowance			3,507		0
	Goodwill impairment loss			57		15,615
	Prior year true up			-715		-33
	Other			25		12
	Benefit from income taxes		$	-3,038	$	-2,969

Derivative_Instruments_And_Hed

Derivative Instruments And Hedging Activities	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES	'
	16	DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
	Derivatives held by us as of December 31, 2013 consist of the following (all amounts in thousands):
	Derivative Instrument		Balance Sheet Location		Fair Value
	Currency forward contracts		Derivatives liability (current liabilities)		$	0
	Interest rate swaps		Derivatives liability (current liabilities)			0
	Derivatives held by us as of December 31, 2012 consist of the following (all amounts in thousands):
	Derivative Instrument		Balance Sheet Location		Fair Value
	Currency forward contracts		Prepaid expenses and other current assets		$	-14
	Interest rate swaps		Derivatives liability (noncurrent liabilities)			-155
	Currency Forward Contracts
	CTSAS’ functional currency is the Euro. Periodically, CTSAS purchases inventory from CTI, which requires payment in U.S. dollars. Beginning in 2009, and only under certain circumstances, the Company utilizes currency forward contracts to mitigate CTSAS’ exposure to changes in the Euro-to-U.S. dollar exchange rate upon payment of these inventory purchases. Such currency forward contracts typically have durations of less than six months. These currency forward contracts are reported at their fair value. This relationship has not been designated as a hedge and therefore all changes in these currency forward contracts’ fair value are recorded in other income, net within the accompanying consolidated statements of comprehensive loss. The Company held one such currency forward at December 31, 2012. See Note 23 for a description of how the Company estimates the fair value of these contracts.
	Interest Rate Swaps
	In December 2008, the Company entered into two pay-fixed, receive-variable, interest rate swaps to reduce exposure to changes in cash payments caused by changes in interest rates on the Term Loan and the Real Estate Loan. Both relationships are designated as cash flow hedges and meet the criteria for the shortcut method for assessing hedge effectiveness; therefore, the hedge is assumed to be 100% effective and all changes in the fair value of the interest rate swaps are recorded in comprehensive income (loss). See Note 20 for a description of changes in accumulated other comprehensive income (loss) due to derivatives and hedging activities. Such changes were due to unrealized gains and losses on the interest rate swaps. These unrealized gains and losses must be reclassified in whole or in part into earnings if, and when, a comparison of the swap(s) and the related hedged cash flows demonstrates that the shortcut method is no longer applicable. These hedges met the criteria of the shortcut method for the duration of the hedging relationship, which ended on December 19, 2013, and therefore, the Company will not reclassify any portion of these unrealized losses from accumulated other comprehensive loss to earnings in the future. See Note 23 for a description of how the fair value of these swaps was estimated.
	Effect of Derivatives on Statements of Comprehensive Loss
	The effect of derivative instruments (a) designated as cash flow hedges and (b) not designated as hedging instruments on our consolidated statement of comprehensive loss for year ended December 31, 2013 was as follows (all amounts in thousands):
			Gain (Loss)			Gain (Loss)		Gain (Loss)
			In AOCL (1)			Reclassified (2)		in Earnings (3)
	Derivatives designated as cash flow hedges:
	Interest rate swaps, net of taxes of $(59)		$	97		$	0	$	0
	Derivatives not designated as hedging instruments:
	Currency forward contracts		$	0		$	0	$	0
		-1	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2013.
		-2	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2013.
		-3	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2013.
	The effect of derivative instruments (a) designated as cash flow hedges and (b) not designated as hedging instruments on our consolidated statement of comprehensive loss for year ended December 31, 2012 was as follows (all amounts in thousands):
			Gain (Loss)			Gain (Loss)		Gain (Loss)
			In AOCL (1)			Reclassified (2)		in Earnings (3)
	Derivatives designated as cash flow hedges:
	Interest rate swaps, net of taxes of $(45)		$	73		$	0	$	0
	Derivatives not designated as hedging instruments:
	Currency forward contracts		$	0		$	0	$	-18
		-1	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2012.
		-2	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2012.
		-3	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2012.

Asset_Retirement_Obligation

Asset Retirement Obligation	12 Months Ended
	Dec. 31, 2013
Asset Retirement Obligation Disclosure [Abstract]	'
ASSET RETIREMENT OBLIGATION	'
		17	ASSET RETIREMENT OBLIGATION
	The Company has an obligation to remediate certain known occurrences of asbestos at our manufacturing facility in West Springfield, Massachusetts. The significant assumptions used to estimate the obligation are:
	Annual inflation rate			5.54	%
	Credit-adjusted risk-free rate			5.37	%
	Initial estimated remediation costs (undiscounted and not adjusted for inflation)			$200,000 ($41,000 paid in 2007)
	Estimated remediation completion date			19-Dec-38
	Estimated remediation cost on December 19, 2038		$	720,000
	The following is a reconciliation of the beginning and ending aggregate carrying amounts of the asset retirement obligation for the years ended December 31, 2013 and 2012 (all amounts in thousands):
			Year Ended December 31,
			2013			2012
	Balance, beginning		$	184		$	175
	Accretion expense			10			9
	Balance, ending		$	194	-1	$	184
		-1	The difference between the $194,000 liability as of December 31, 2013 and the estimated undiscounted future payments of $720,000 is estimated inflation between December 31, 2013 and December 19, 2038.
	Accretion expense on the asset retirement obligation is included in general and administrative expenses in the accompanying consolidated statements of comprehensive loss.

Commitments_And_Contingencies

Commitments And Contingencies	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	18.   COMMITMENTS AND CONTINGENCIES
	Operating Leases
	The Company leases certain equipment, automobiles and other assets under cancelable and non-cancelable operating leases. Expenses associated with these leases totaled $638,000 and $439,000 in 2013 and 2012, respectively.
	Included in these leases is a market-based, related-party lease which CSP assumed in conjunction with the business combination. CSP entered into the lease with an entity controlled by one of our stockholders for industrial-use property located in Bound Brook, New Jersey, U.S.A. The lease ends on August 31, 2016, with extension options available, and requires lease payments of $24,000 per month from September 1, 2011 through August 31, 2013. The monthly lease payment was adjusted to $30,000 per month beginning September 1, 2013 to reflect the changes of average cost per square foot as reported by Newmark Knight and Frank in their 2nd Quarter 2013 New Jersey Industrial Market Report, Average Asking Rate for Somerset County.
	Future minimum lease payments under non-cancelable lease obligations at December 31, 2013 are as follows (all amounts in thousands):
	Year Ending December 31,
	2014		$	687
	2015			628
	2016			483
	2017			238
	2018			59
	Thereafter			0
			$	2,095
	Legal
	Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts
	On January 23, 2006, before the Company owned CTI, the former owners of CTI (from whom CTI was purchased) (the “Former Owners”) acquired all of the outstanding capital stock of Omniglow Corporation (the “Transaction”) and changed the name of the company to Cyalume Technologies, Inc. Prior to, or substantially simultaneously with, the Transaction, CTI sold certain assets and liabilities related to Omniglow Corporation’s novelty and retail business to certain former Omniglow Corporation stockholders and management (“the Omniglow Buyers”). This was done because CTI sought to retain only the Omniglow Corporation assets and current liabilities associated with its government, military and safety business. During 2006, CTI and the Omniglow Buyers commenced litigation and arbitration proceedings against one another. Claims include breaches of a lease and breaches of various other agreements between CTI and the Omniglow Buyers. These proceedings are known as Civil Action No. 06-706 in Superior Court of the Commonwealth of Massachusetts (the “Court”).
	On December 19, 2008, while Civil Action 06-706 was still unresolved, the Company acquired CTI (the “Acquisition”). According to the Stock Purchase Agreement between the Former Owners and the Company, the Former Owners retained the responsibility for paying for all costs and liabilities associated with Civil Action No. 06-706.
	On July 18, 2011, CTI received an Order for Entry of Final Judgment in Civil Action No. 06-706 in which the Court awarded approximately $2.6 million in damages to Omniglow, LLC. Prejudgment interest at the rate of twelve (12%) percent per annum since the filing of the complaint in 2006 accrues on approximately $1.3 million of the damages. The Court also awarded Omniglow, LLC reimbursement of attorney fees and costs of approximately $235,000, on which interest at the rate of twelve (12%) percent per annum accrues beginning with the date of the final ruling.
	On July 12, 2012, the Court issued an Amended Final Judgment and, on September 20, 2012, a Final Judgment. There were no changes to the previously described damage awards. In response, on October 17, 2012, the Company filed a Notice of Appeal and on August 2, 2013, the Company filed a Formal Appeal, which contains a number of bases for overturning the awards. Oral arguments were made by the parties before the Appellate Court during January of 2014. The Company can not determine when a decision will be rendered. The Company holds 625,139 shares of the Company’s common stock in escrow which may be applied against any damages up to the value of the shares upon conversion to cash.
	The Company has appealed the final judgment and previously recorded a contingent legal obligation in the full amount of the final ruling (now approximately $4.0 million). Since the Former Owners (i) retained the responsibility for paying the costs and liabilities associated with Civil Action No. 06-706 and (ii) are related parties under U.S. GAAP due to their ownership interest in us and their membership on our board of directors, the Company previously recorded approximately $4.3 million, which includes the $3.6 million contingent legal obligation and other costs incurred while litigating Civil Action No. 06-706, within due from related party, net on the consolidated balance sheet as of September 30, 2013. The due from related party, net was offset by an allowance of approximately $3.7 million as of September 30, 2013, which was recorded on the provision for uncollectible receivable – related party line item on the Company’s consolidated statement of comprehensive loss. On November 19, 2013, a Release and Escrow Agreement was executed whereby the Company released affiliates of the Former Owners from being obligated on the costs and liabilities associated with Civil Action No. 06-706 in exchange for 625,139 shares of Cyalume stock placed in escrow (the “Escrowed Shares”). The Escrowed Shares provide the Company with a source of recovery with respect to any loss, liability or expenses incurred by the Company in connection with Civil Action No. 06-706. The Company reflected the value of the 625,139 Escrowed Shares at December 31, 2013 based upon the close price of Cyalume’s stock on December 31, 2013. The December 31, 2013 value of the Escrowed Shares is included within the other assets line item and approximately $4.0 million is included within the contingent legal obligation line item on the Company’s consolidated balance sheet as of December 31, 2013.
	Demand for Arbitration by Former Employee
	On December 22, 2011, CTI entered into a Stock Purchase Agreement (“SPA”) with Combat Training Solutions, Inc. (“CTS”) and Antonio Colon, the sole stockholder of CTS. Pursuant to the SPA, CTI purchased all of the issued and outstanding capital stock of CTS in return for consideration that included contingent consideration ranging from $0 to $5.75 million , which is based on CTS’ financial performance during the period of December 22, 2011 through December 31, 2013 (the “Measurement Period”). The SPA also contains provisions that if Mr. Colon is terminated without cause during the Measurement Period, then the maximum potential contingent consideration amount of $5.75 million becomes payable to Mr. Colon on the first business day after January 1, 2014.
	On June 15, 2012, the Company received a copy of a demand for arbitration filed by Mr. Colon with the American Arbitration Association. The demand alleges, among other things, that CTI has constructively terminated Mr. Colon’s employment without cause and that Cyalume and CTI have breached certain provisions of the SPA. Mr. Colon seeks, among other things, payment of the maximum potential contingent consideration amount of $5.75 million, payment of salary, wages, bonuses and benefits pursuant to Mr. Colon’s employment agreement with CTI, and reimbursement of his attorneys’ fees and costs related to this matter. Management considered the allegations by Mr. Colon to be without merit and therefore no accrual was previously recorded for this matter.
	On August 17, 2012, Mr. Colon filed suit in Federal Court and on September 11, 2012, he filed to have the arbitration withdrawn. In addition, on September 11, 2012, Mr. Colon chose to cease working for the Company.
	CTI filed a Motion to Dismiss the Complaint in Federal Court and to compel the controversy to arbitration before the American Arbitration Association. The District Court for the District of Delaware held a hearing on January 23, 2013, at which it dismissed the Complaint in Federal Court without prejudice and indicated that the arbitration should proceed. On September 23, 2013, the parties entered into an agreement to resolve this matter, and a settlement agreement was signed on November 19, 2013. The executed settlement agreement calls for the Company to make a series of payments over five years to Mr. Colon in the amount of $215,000 annually, for a total of $1,075,000 pursuant to the Promissory Note executed on November 19, 2013. The Company also made a settlement payment of $275,000 on November 20, 2013 and transferred the land located in Colorado (this land was originally acquired by CTI in connection with the 2011 CTS acquisition) to JasperCo, LLC pursuant to the terms of the executed settlement agreement with Antonio Colon. The total legal settlement amount recorded in the Company’s accompanying consolidated statement of comprehensive loss for the twelve months ended December 31, 2013 incurred in connection with settling the matter described above was approximately $2.0 million and is comprised of the following: approximately $631,000 relating to the Colorado land transfer, approximately $63,000 accrued in connection for the tax burden incurred by JasperCo, LLC for the transfer of the Colorado land, a Promissory Note for $1,075,000 payable over five years and approximately $275,000 paid on November 20, 2013 in connection with the execution of the settlement agreement.
	Agreement with Board Member
	On October 1, 2009, the Company entered into an agreement with Selway Capital, LLC (“Selway”) that provides for (but is not limited to) the following services to be performed by Selway on the Company’s behalf:
		·	Strategic development and implementation as well as consultation to the chief executive officer on a regular basis as per his reasonable requests;
		·	Identifying strategic partners with companies with which Selway has relationships and access. In this connection, Selway will focus on building partnerships with companies in Israel, Singapore, India and Europe. The focus will be on the expansion of our munitions business;
		·	Advise and support the Company’s investor relations strategy;
		·	Advise and support future fund raising, including identifying sources of capital in the United States; and
		·	Support the Company’s mergers and acquisitions strategy and play an active role in due diligence and analysis.
	The agreement stipulates that these services would be performed by Yaron Eitan, an employee of Selway and a member of the Company’s Board of Directors, with assistance, as needed, from other employees of Selway. The agreement, which expired on October 1, 2012, was extended through December 31, 2013 and will terminate on March 31, 2014. Per the amendment to extend the agreement, Selway’s compensation for these services was reduced from $21,000 per month to $11,000 per month effective January 1, 2014. Selway is reimbursed for costs incurred specifically on the Company’s behalf for these services. Included within accrued expenses at December 31, 2013 is approximately $158,000 relating to Selway fees which are expected to be settled in shares of the Company’s common stock during 2014.

Preferred_Stock

Preferred Stock	12 Months Ended
	Dec. 31, 2013
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'
PREFERRED STOCK	'
		19	PREFERRED STOCK
	Convertible Preferred Stock
	The Company is authorized to issue 1,000,000 shares of preferred stock with such designations, voting and other rights and preferences as may be determined from time to time by our Board of Directors.
	On November 19, 2013, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with US VC Partners, L.P. (the “Investor”) for the purchase by the Investor of 123,077 units of securities of the Company for an aggregate purchase price of $4.0 million (or $32.50 per unit). Each security issued is comprised of: 1) one share of Series A Convertible Preferred Stock of the Company, at a par value of $0.001 per share (the “Series A Preferred Stock”); 2) one common stock warrant ( the “Common Warrant”); and 3) one preferred stock warrant (the “Preferred Warrant”).
	Since the Common Warrant and the Preferred Warrant are not indexed to the Company’s stock, they are derivatives and therefore, are being accounted for as a liability.
	Upon voluntary or involuntary liquidation, dissolution or winding up of the Company, each holder of Series A Preferred Stock is entitled to a liquidation preference of $32.50 per share, plus any accrued but unpaid dividends, subject to customary adjustments as set forth in the Certificate of Designation (the “Liquidation Value”).
	Each share of Series A Preferred Stock may be converted at any time at the option of the holder into a number of shares of common stock initially equal to 50 shares of common stock, determined by dividing the Liquidation Value per share of Series A Preferred Stock by the applicable conversion price per share of Series A Preferred Stock. The initial conversion price shall equal $0.65, subject to customary adjustments, including for any accrued but unpaid dividends and pursuant to certain anti-dilution provisions. The Series A Preferred Stock is not subject to mandatory conversion at any time.
	Dividends on the Series A Preferred Stock accrue (payable in cash or in kind), whether or not declared by the Board and whether or not funds are available for the payment of dividends, at a rate of 12% per annum on the sum of the liquidation preference plus all accrued and accumulated dividends and will be payable quarterly in arrears in a) cash or b) newly issued shares of Series A Preferred Stock having an aggregate liquidation preference equal to the amount of such accrued dividends (“PIK Dividends”) at the option of the Company. All accrued and accumulated dividends on the convertible preferred stock shall be paid prior to and in preference to any other class of securities of the Company.
	Each share of Series A Preferred Stock will be entitled to a number of votes equal to the number of shares of common stock into which such share is convertible and shall be entitled to vote with holders of outstanding shares of common stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration.
	The requisite holders of the Series A Preferred Stock will have the right to cause the Company to redeem, out of funds legally available, all but not less than all of the then outstanding shares of Series A Preferred Stock, for a price per share equal to the Liquidation Value of such shares from and after the fifth anniversary of the closing date of the Purchase Agreement. Additionally, the Company will have the right to redeem all of the outstanding shares of Series A Preferred Stock from and after the eighth anniversary of the closing date of the Purchase Agreement at a redemption price equal to the Liquidation Value. As a result of the redemption provisions, the Series A Preferred Stock has been classified outside of permanent equity.
	Common and Preferred Warrants
	In connection with the Series A Preferred Stock issued on November 19, 2013, the Company also issued a Common Warrant for the purchase of up to 6,153,830 shares of common stock at an exercise price of $0.65 per share. The estimated fair value of the Common Warrants is determined at each balance sheet date and the change in the estimated fair value of the Common Warrant is reflected within the “Change in fair value of warrants liability” within the accompanying statements of comprehensive loss.
	The fair value as of December 31, 2013 of the Common Warrant is estimated using the Monte Carlo simulation method with the following inputs:
			Common Warrant
	Stock price of underlying equity		$	0.69
	Exercise price		$	0.65
	Expected volatility (standard deviation)			100	%
	Annual risk-free rate			3.04	%
	Expected term (time to expiration years)			9.9
	Number of periods			514
	Period interval			0.019
	Period risk-free rate			0.058	%
	Number of simulations			500,000
	In connection with the Series A Preferred Stock issued on November 19, 2013, the Company also issued a Preferred Warrant for the purchase of up to 123,077 shares of Series A Preferred Stock with an exercise price of $0.05 per share. The estimated fair value of the Preferred Warrant is determined at each balance sheet date and the change in the estimated fair value of the Preferred Warrant is reflected within the “Change in fair value of warrants liability” within the accompanying statements of comprehensive loss.
	The fair value as December 31, 2013 of the Preferred Warrant is estimated using the Black-Scholes pricing model with the following inputs:
			Preferred Warrant
	Stock price of underlying equity		$	32.5
	Exercise price		$	0.05
	Expected term (years)			1.7
	Risk-free interest rate			0.13	%
	Estimated dividend yield			None
	Volatility			70	%
	The change in the fair value of the warrants liability during the year ended December 31, 2013 is as follows (amounts in thousands):
			Common			Preferred		JFC Warrant		Subordinated Term Loan Warrants		Total Warrant
			Warrant			Warrant		(see Note 13)		(see Note 12)		Liability
	Warrant liability at December 31, 2012		$	0		$	0	$	0	$	0	$	0
	Fair value recorded on the November 19, 2013 transaction date			3,556			1,997		54		241		5,848
	Change in fair value of warrants			525			0		0		0		525
	Warrant liability at December 31, 2013		$	4,081		$	1,997	$	54	$	241	$	6,373

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
STOCKHOLDERS' EQUITY	'
		20	STOCKHOLDERS’ EQUITY
	Common Stock
	The Company is authorized to issue 100,000,000 shares of common stock. Common stockholders are entitled to one vote for each share held of record on all matters to be voted on by stockholders. Common stockholders have no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the common stock.
	Common Stock Purchase Warrants
	Common stock purchase warrants accounted for within equity are recorded at their initial fair value and reported in stockholders’ equity as increases to additional paid-in capital. Warrants reported as equity, rather than liabilities (i) may not be net-cash settled, (ii) the warrant contract limits the number of shares to be delivered in a net-share settlement and (iii) the Company has sufficient unissued common shares available to settle outstanding warrants. Subsequent changes in fair value from the warrants’ initial fair value are not recognized as long as the warrants continue to merit classification as equity.
	At December 31, 2012, warrants to purchase 160,000 shares of the Company’s common stock issued in conjunction with the Subordinated Term Loan were outstanding (see Note 12). These warrants were amended again during 2013 in connection with the Senior Amendment described in Note 12. An additional amount of approximately $199,000 was added to debt discount and warrant liability during 2013 relating to (i) another decrease in the exercise price of the warrants to $0.01, (ii) an extension of the term of the warrants, and (iii) an increase to the number of shares of common stock that may be purchased upon exercise of the warrants to 455,514 shares of common stock that may be purchased. As of December 31, 2013, warrants to purchase 455,514 shares of the Company’s common stock issued relating to the Subordinated Term Loan were outstanding.
	Warrants to purchase the Company’s common stock were outstanding as follows as of December 31, 2013:
	Warrant Holder		Number of			Exercise			Expiration Date
			Shares			Price
			Exercisable
			Under Warrant
	US VC Partners, L.P.			6,153,850		$	0.65		19-Nov-23
	JFC Technologies LLC			73,009			0.01		19-Nov-23
	Granite Creek FlexCap I, L.P.			267,950			0.01		19-Nov-23
	Patriot Capital II, L.P.			187,564			0.01		19-Nov-23
	Share-Based Compensation
	On March 3, 2009, our Board of Directors adopted the Cyalume Technologies Holdings, Inc. 2009 Omnibus Securities and Incentive Plan (the “Plan”). The Plan was approved during our Annual Meeting of Stockholders on June 18, 2009. The purpose of the Plan is to benefit stockholders by assisting us in attracting, retaining and providing incentives to key management employees and non-employee directors of, and non-employee consultants to, Cyalume Technologies Holdings, Inc. and its subsidiaries, and to align the interests of such employees, non-employee directors and non-employee consultants with those of stockholders. Accordingly, the Plan provides for the granting of Distribution Equivalent Rights, Incentive Stock Options, Non-Qualified Stock Options, Performance Share Awards, Performance Unit Awards, Restricted Stock Awards, Stock Appreciation Rights, Tandem Stock Appreciation Rights, Unrestricted Stock Awards or any combination of the foregoing, as may be best suited to the circumstances of the particular employee, director or consultant as provided herein. Under the Plan, we are authorized to issue up to 2.0 million shares of common stock, increased by the Board of Directors to 2.65 million in December 2012, which was approved by the stockholders at the 2013 Annual Meeting of Stockholders. As of December 31, 2013, 848,666 shares were available for future awards under the Plan. Awards under the Plan can impose various service periods and other terms upon the awardee; however, the maximum term of options or similar instruments granted under the Plan is ten years.
	Share-based awards are also issued that are not under the Plan. In September 2012, the Company awarded options to purchase our common stock to our Chief Operating Officer as part of his employment compensation. These options were not awarded under the Plan. Also in September 2012, the Company awarded options to purchase our common stock to East Shore Ventures, LLC as part of compensation for Chief Executive Officer services provided by East Shore Ventures, LLC’s owner and employee. These options were also not awarded under the Plan. Because East Shore Ventures, LLC is not considered to be an employee under U.S. GAAP rules for accounting for share-based payments, the Company must estimate the fair value of these options every reporting period and adjust the related compensation cost accordingly. These two awards are included in the section titled “Stock Option and Warrant Awards” below.
	During the years ended December 31, 2013 and 2012, total expense recorded for share-based compensation was approximately $773,000 and $503,000, respectively. The following presents how share-based expenses are included in our consolidated statements of comprehensive loss (in thousands):
			Year Ended December 31,
			2013			2012
	Cost of revenues		$	9		$	12
	Sales and marketing			44			-12
	General and administrative			621			387
	Research and development			99			116
			$	773		$	503
	The Company does not currently possess any treasury shares; therefore any issuance of stock for any share-based compensation award is expected to be from new shares.
	Stock Option and Warrant Awards
	The Black-Scholes pricing model is used to value all stock options and warrants awarded as share-based compensation. The expected term of the options and warrants awarded under share-based compensation arrangements individually is estimated based on the estimated term of the award, the exercise price of the award, the estimated risk-free interest rate over the award’s estimated term, estimated annual dividend yield, and the estimated volatility of the price of our common stock over the award’s estimated term. Risk-free interest rate assumptions are based on U.S. Treasury securities issued with maturities similar to the expected terms of the awards. In September 2012, the Company began estimating the future volatility of the price of our common stock using historical daily prices of our common stock; before September 2012, since our common stock had insufficient trading history to estimate future price volatility, volatility was using historical data of another public company operating in our industry.
	The fair value of each award is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions for awards to employees and non-employees:
			2013				2012
	Expected term (years)			5.0 – 6.5				5.0 – 6.5
	Risk-free interest rate			1.10 – 1.70	%			.73 – 1.43	%
	Estimated dividend yield			None				None
	Volatility			126.71 – 130.08	%			26.45 – 128.16	%
	Stock options and warrants awarded as of December 31, 2012 will generally vest in zero to 5 years. Options awarded to executive officers and other management typically are earned based on meeting Board-determined or CEO-determined performance goals unique to each award recipient and require continued employment over the vesting period. Options awarded to members of the Board of Directors typically vest on the grant date. Options and warrants awarded typically expire 10 years after the grant date.
	Stock option and warrant activity related to share-based compensation is summarized as follows:
			Shares			Weighted Average
			(in thousands)			Exercise Price
	Outstanding at December 31, 2011			1,166			3.44
	Granted (1)			1,708			1.6
	Exercised (2)			-5			3.65
	Forfeited			-24			3.71
	Expired			-3			3.8
	Outstanding at December 31, 2012			2,842			2.33
	Granted (3)			708			1.79
	Exercised			0			-
	Forfeited			-255			2.02
	Expired			-283			3.78
	Outstanding at December 31, 2013			3,012			2.09
	Exercisable at December 31, 2013			1,321		$	2.76
		-1	The weighted-average grant-date fair value of awards granted was $1.33.
		-2	The intrinsic value of awards exercised was $1,000. These options were exercised on a cashless basis, therefore no cash was received at exercise. The tax benefit realized from this exercise was insignificant.
		-3	The weighted-average grant-date fair value of awards granted was $1.61.
	The following table summarizes information about stock options and warrants related to stock-based compensation that (i) are not subject to performance conditions and (ii) are vested or are expected to vest as of December 31, 2013:
										Options Outstanding				Options Exercisable
										Weighted
										Average		Weighted						Weighted
							Number			Remaining		Average		Number				Average
	Range of						Outstanding			Contractual		Exercise		Exercisable				Exercise
	Exercise Prices						(in thousands)			Term (Years)		Price		(in thousands)				Price
	$	0		$	2			2,212			8.3	$	1.57		545		$	1.69
		2.01			4			675			6.18		3.34		668			3.33
	4.01			6			125			6.94		4.61		108			4.61
							3,012	-1		7.77	$	2.09		1,321	-2	$	2.76
	-1	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013.
	-2	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013. The weighted-average remaining contractual term for these options is 6.45 years as of December 31, 2013.
As of December 31, 2013, there was approximately $1,773,000 of unrecognized compensation cost related to nonvested option awards which is expected to be recognized over a weighted-average period of 3.68 years.
Restricted Stock
The Company values stock awards at the closing market price of the underlying shares on the trading day previous to the grant date, adjusted for expected forfeitures.
Nonvested restricted common stock related to stock-based compensation is summarized as follows:
			Shares			Weighted
			(in thousands)			Average Grant
						Date Fair Value
Outstanding at December 31, 2011			277				3.88
Granted			29				2.66
Vested (1)			-129				3.53
Forfeited			-141				3.98
Outstanding at December 31, 2012			36	-3		$	3.76
Granted			0				-
Vested (2)			-36				3.76
Forfeited			0				-
Outstanding at December 31, 2013			0			$	-
	-1	The total fair value of restricted common stock awards that vested during 2012 was $364,000.
	-2	The total fair value of restricted common stock awards that vested during 2013 was $45,000.
	-3	These stock awards vested upon fulfilling service conditions.
As of December 31, 2012, there was $52,000 of unrecognized compensation cost related to nonvested stock awards which was recognized in 2013.
Accumulated Other Comprehensive Loss
The ending accumulated balances for each item in accumulated other comprehensive loss are as follows (all amounts in thousands):
		Year Ended December 31,
		2013			2012
Foreign currency translation loss		$	-218		$	-418
Unrealized gain on cash flow hedges, net of taxes			0			-97
		$	-218		$	-515
Changes in accumulated other comprehensive loss due to derivative instruments and hedging activities are as follows (all amounts in thousands):
Balance, December 31, 2011		$	-170
Unrealized gain on interest rate swaps, net of taxes of $(45)			73
Balance, December 31, 2012			-97
Unrealized gain on cash flow hedges, net of taxes of $(59)			97
Balance, December 31, 2013		$	0
Changes in accumulated other comprehensive loss due to currency translation adjustments (all amounts in thousands):
Balance, December 31, 2011		$	-526
Adjustments due to translation of CTSAS financial statements from Euros into U.S. Dollars			108
Balance, December 31, 2012			-418
Adjustments due to translation of CTSAS financial statements from Euros into U.S. Dollars			200
Balance, December 31, 2013		$	-218

Employee_Benefit_Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]	'
EMPLOYEE BENEFIT PLANS	'
	21	EMPLOYEE BENEFIT PLANS
	The CTI Employee Savings and Retirement Plan (the “ESRP”), is intended to be qualified under Section 401(k) of the Internal Revenue Code. Employees of CTI, CTS and CSP who have reached the age of 18 are eligible for participation on the first entry date after three months of service. Entry dates are the first day of January, April, July and October. Employees may defer receiving compensation up to the maximum amount permitted under the Internal Revenue Code. Matching contributions to the ESRP equal (i) 3% of employee compensation plus (ii) 50% of the next 2% of employee compensation. For the years ended December 31, 2013 and 2012, employer matching contributions were $263,000 and $242,000, respectively.
	French law requires companies within France (such as CTSAS) to pay its workers a benefit, based on various factors, when an employee becomes 65 years old.  The Company estimated the present value of such a liability for employees at CTSAS and approximately $79,000 has been recorded for this obligation as of December 31, 2013.

Concentrations

Concentrations	12 Months Ended
	Dec. 31, 2013
Risks and Uncertainties [Abstract]	'
CONCENTRATIONS	'
		22	CONCENTRATIONS
	Sales Concentrations
	In 2013, approximately 23% of the Company’s revenue was received from one customer. In 2012, approximately 40% of the Company revenue was received from two customers.
	Geographic Concentrations
	The Company sells to customers located in the United States of America and in international markets. Revenues to customers outside the United States represent 32% and 28% of net revenues for the years ended December 31, 2013 and 2012, respectively. Revenues from customers in the United Kingdom represented 5% and 9% of our 2013 and 2012 revenues, respectively.
	CTSAS’ operations are our only operations outside the United States of America. CTSAS’ net assets were approximately $5,245,000 and $6,278,000 as of December 31, 2013 and 2012, respectively.
	Concentrations of Credit Risk Arising from Financial Instruments
	As of December 31, 2013, three customers combined represented 47% of gross accounts receivable and no other customer owed more than 10% of gross accounts receivable. All of these accounts receivable were collected in full in the first quarter of 2014. As of December 31, 2012, three customers combined represented 39% of gross accounts receivable and no other customer owed more than 10% of gross accounts receivable.
	The Company maintains cash in several different financial institutions in amounts that typically exceed U.S. federally insured limits and in financial institutions in international jurisdictions where insurance is not provided. The Company has not experienced any losses in such accounts and the Company believes it is not exposed to significant credit risk. All cash maintained in U.S. non-interest bearing cash accounts were fully insured at December 31, 2012 due to a temporary federal program in effect from December 31, 2010 through December 31, 2012. Under the program, there is no limit to the amount of insurance for eligible accounts. Beginning in 2013, insurance coverage reverted to $250,000 per depositor at each financial institution and the cash balances exceed federally-insured limits by approximately $90,000. As of December 31, 2013, cash in non-U.S. bank accounts that were not insured by a federal government totaled approximately $328,000.

Fair_Values_of_Assets_And_Liab

Fair Values of Assets And Liabilities	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
FAIR VALUES OF ASSETS AND LIABILITIES	'
		23	FAIR VALUES OF ASSETS AND LIABILITIES
	Assets and Liabilities Measured at Fair Value on a Recurring Basis
	Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2013:
			Level 1
			Quoted
			Prices in
			Active			Level 2
			Markets			Significant			Level 3		Assets/
			for			Other			Significant		(Liabilities)
			Identical			Observable			Unobservable		At Fair
			Assets			Inputs			Inputs		Value
	Interest rate swaps (see Note 16) (1)		$	0		$	0			0	$	0
	Currency forward contracts (see Note 16) (2)			0			0			0		0
	Warrants (see Note 19)(3)			0			0			-6,373		-6,373
			$	0		$	0		$	-6,373	$	-6,373
		-1	The fair values of the swaps are determined by discounting the estimated cash flows to be received and paid due to the swaps over the swap’s contractual lives using an estimated risk-free interest rate for each swap settlement date (an income approach).
		-2	The fair value of these contracts is determined by multiplying the notional amount of the contract by the difference between (a) the U.S. dollar amount due on the contract at maturity and (b) the foreign exchange rate as of the date the contract is valued (the balance sheet date). Because the contracts typically have a short duration, the value is not discounted using a present value technique (an income approach).
		-3	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
	Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2012:
			Level 1
			Quoted
			Prices in
			Active			Level 2
			Markets			Significant			Level 3		Assets/
			for			Other			Significant		(Liabilities)
			Identical			Observable			Unobservable		At Fair
			Assets			Inputs			Inputs		Value
	Interest rate swaps (see Note 16) (1)			0		$	-155			0	$	-155
	Currency forward contracts (see Note 16) (2)			0			-14			0		-14
			$	0		$	-169		$	0	$	-169
		-1	The fair values of the swaps are determined by discounting the estimated cash flows to be received and paid due to the swaps over the swap’s contractual lives using an estimated risk-free interest rate for each swap settlement date (an income approach).
		-2	The fair value of these contracts is determined by multiplying the notional amount of the contract by the difference between (a) the U.S. dollar amount due on the contract at maturity and (b) the foreign exchange rate as of the date the contract is valued (the balance sheet date). Because the contracts typically have a short duration, the value is not discounted using a present value technique (an income approach).
	The tables below presents reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2013 and 2012:
			Year Ended December 31,
			2013			2012
	Warrants liability:
	Balance at the beginning of period		$	0		$	0
	Fair value recorded on the November 19, 2013 transaction date			5,848			0
	Change in fair value of warrants			525			0
	Balance at the end of period		$	6,373		$	0
			Year Ended December 31,
			2013			2012
	Contingent consideration:
	Balance at the beginning of period		$	0		$	-3,699
	Initial recognition of the liabilities			0			0
	Unrealized gains (losses) in earnings			0			-3,380
	Finalization of the fair value determination of contingent consideration in the CTS acquisition			0			-166
	Payment of contingent consideration from the CSP acquisition			0			7,245
	Balance at the end of period		$	0		$	0
	The Company has other financial instruments, such as cash, accounts receivable, due from related party, accounts payable, notes payable and line of credit. The Company believes the carrying amounts of those assets and liabilities approximate their fair value since those carrying amounts have been estimated to approximate the exit price which would be received to sell these assets or pay to transfer these liabilities to a market participant. See Note 2 for a discussion of our accounting policy regarding fair value.
	Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
	During the year ended December 31, 2013, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see also Note 3):
			Cyalume Reporting Unit (1)		Loss Recognized			Fair Value
	Goodwill (2)		CTS Training		$	168		$	0
	Patents (3)		CTS Training			174			17
	Trade name (4)		CTS Training			17			0
	Non-compete agreements (5)		CTS Training			34			0
	Customer Relationships		CTS Training			650			60
	During the year ended December 31, 2012, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see also Note 3):
			Cyalume Reporting Unit (1)		Loss Recognized			Fair Value
	Goodwill (2)		Chemical Light		$	46,230		$	5,014
	Goodwill (2)		Training			858			351
	Patents (3)		Training			172			210
Trade name (4)		Training			29			30
Non-compete agreements (5)		Training			80			40
Certain equipment (6)		Chemical Light			273			0
	-1	The Company managed as one operating segment with four reporting units: Chemical Light (the operations of CTI and CTSAS), CTS Training (the operations of CTS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Specialty Products’ goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
	-2	The fair value of the impaired goodwill asset was determined calculating the excess of the fair value of the reporting unit over the fair values assigned to its assets and liabilities and utilized present value techniques utilizing each reporting unit’s forecasted after-tax cash flows.
	-3	The fair value of the impaired patent asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).
	-4	The fair value of the impaired trademarks and trade names asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).
	-5	The fair value of the impaired non-compete agreement asset was determined using the “comparative business valuation” method, which compares the present value of two streams of the reporting unit’s estimated future cash flows; one stream assuming the non-compete agreements are in place and the other stream assuming the agreements are not in place (an income approach).
	-6	The fair value of the impaired equipment was determined estimating the present value of cash flows expected to result from the use and disposition of the equipment (an income approach).

Supplemental_Disclosure_of_Cas

Supplemental Disclosure of Cash Flow Information	12 Months Ended
	Dec. 31, 2013
Supplemental Cash Flow Elements [Abstract]	'
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION	'
		24	SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
	Cash Paid for Interest and Income Taxes (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Interest		$	1,693	$	1,762
	Income taxes			133		554
	Non-Cash Investing and Financing Activities (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Series A Convertible Preferred stock in-kind dividend		$	55	$	0
	Series A Convertible Preferred stock deemed dividend			4,000		0
	Warrants liability recorded in connection with common and preferred warrants			5,607		0
	Amendment and adjustment to the fair value of warrants issued in conjunction with issuance of subordinated term loan recorded within warrant liability			241		94
	Adjustment to goodwill acquired and contingent consideration incurred in the acquisition of CTS due to the finalization of the fair value of the contingent consideration			0		166
	Adjustment to goodwill acquired and deferred tax liability incurred in the acquisition of CTS due to the finalization of the fair value of the business combination			0		64
	Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets			0		183
	Issuance of 2,450,000 shares of our common stock to repay the contingent consideration liability resulting from the acquisition of CSP			0		5,145
	Issuance of a $2,100,000 note payable to repay the contingent consideration liability resulting from the acquisition of CSP			0		2,100
	Issuance of 22,500 shares of our common stock to settle litigation claim			0		56

Schedule_II_Valuation_and_Qual

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2013
Valuation and Qualifying Accounts [Abstract]	'
Valuation and Qualifying Accounts	'
	Consolidated Financial Statement Schedule
	Schedule II – Valuation and Qualifying Accounts
	(in thousands)
				Additions
				Charged		Charged to
			Balance at	to costs		other					Balance
			Beginning	and		accounts		Deductions			at End of
	Description		of Period	expenses		(Describe)		(Describe)			Period
	Year ended December 31, 2012
	Allowance for Doubtful Accounts		206		-1		—		-50	-1	155
	Deferred Tax Asset Valuation Allowance		3,874		—		—		—		3,874
	Year ended December 31, 2013
	Allowance for Doubtful Accounts		155		2		—		-113	-2	44
	Deferred Tax Asset Valuation Allowance		3,874		2,048		—		—		5,922
		-1	Write-offs ($49,000) and recoveries of reserved receivables ($1,000)
		-2	Write-offs and recoveries

Significant_Accounting_Policie1

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Reclassifications	'
	Reclassifications
	Certain prior year amounts have been reclassified to conform to the current year presentation.
Foreign Operations	'
	Foreign Operations
	The accounting records of our France-based subsidiary CTSAS are maintained in Euros, their local and functional currency. For consolidation, revenue and expense transactions are translated to U.S. dollars using the average exchange rate of the month in which the transaction took place. Assets and liabilities are translated to U.S. dollars using the exchange rate in effect as of the balance sheet date. Equity transactions are translated to U.S. dollars using the exchange rate in effect as of the date of the equity transaction. Translation gains and losses are reported as a component of accumulated other comprehensive income within stockholders’ equity. Gains and losses resulting from transactions which are denominated in other than the functional currency are reported as other income or loss in the statement of comprehensive income (loss) in the period the gain or loss occurred.
Comprehensive Loss	'
	Comprehensive Loss
	Comprehensive loss accounts for changes in stockholders’ equity resulting from non-stockholder sources. All transactions that would cause comprehensive loss to differ from net loss have been recorded and disclosed and relate to (i) the translation of the accounting records of our France-based subsidiary CTSAS and (ii) the effective portion of activities designated as hedges for hedge accounting purposes.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Estimates are used when accounting for certain items such as reserves for inventory, accounts receivable and deferred tax assets; assessing the carrying value of intangible assets including goodwill; determining the useful lives of property, plant and equipment and intangible assets; determining asset retirement obligations; and determining the fair value of contingent consideration. Estimates are based on historical experience, where applicable, and assumptions that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved with estimates, actual results may differ.
Accounts Receivable	'
	Accounts Receivable
	Accounts receivable are recorded at the aggregate unpaid amount less any allowance for doubtful accounts. The allowance is based on historical bad debt experience and the specific identification of accounts deemed uncollectible. An account receivable’s delinquency status is determined based on its contractual terms. Interest is not charged on outstanding balances. Accounts are written off only when all methods of recovery have been exhausted. Credit risk is controlled through initial credit evaluations and approvals, credit limits, and monitoring procedures. Ongoing credit evaluations of customers are performed but do not require collateral to secure accounts receivable.
Inventories	'
	Inventories
	Inventories are stated at the lower of cost (on a first-in first-out (“FIFO”) method) or net realizable value. The cost of inventory consists of raw material content, labor costs to produce the inventory and overhead costs incurred during production of the inventory. The Company periodically reviews the realizability of inventory. Provisions are recorded for potential obsolescence which requires management’s judgment. Conditions impacting the realizability of inventory could cause actual write-offs to be materially different than provisions for obsolescence.
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Property, plant and equipment are stated at cost. Depreciation is computed under the straight-line method over the estimated useful lives of four to eight years for equipment and 30 years for buildings and improvements.
	Property, plant and equipment assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. Such reviews are based on a comparison of the asset’s undiscounted cash flows to the recorded carrying value for the asset. If the asset’s recorded carrying value exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset, the asset’s carrying value is written-down to its estimated fair value. To estimate that fair value, the Company uses the most appropriate valuation technique for the circumstances and for which sufficient data is available. Impairment charges, if any, are recorded in the period in which the impairment is determined. In the event of an impairment charge, the identifiable assets’ post-impairment carrying value will continue to be amortized or depreciated over their useful lives and be reviewed periodically for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.
Goodwill	'
	Goodwill
	Goodwill is deemed to have an indefinite life and accordingly, is not subject to amortization. Goodwill is subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon its estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.
Intangible Assets	'
	Intangible Assets
	Intangible assets include developed technologies and patents, customer relationships, non-compete agreements, trademarks and trade names, all of which are amortized over their estimated useful lives. The carrying amounts of amortizing intangible assets are reviewed for impairment whenever events or changes in circumstances indicate that those carrying amounts may not be recoverable and are also reviewed for impairment annually as of August 31.
	Costs incurred to register new patents or defend existing patents are capitalized, while costs to renew or extend the term of intangible assets are expensed when incurred. Costs incurred with third parties that are related to internally developing or successfully defending an intangible asset are capitalized as part of the intangible asset developed or defended and amortized over that asset’s remaining useful life. Such costs with third parties related to patent or trademark applications that are ultimately rejected by the relevant government authority are expensed upon rejection. The useful lives used for amortization of intangible assets are as follows:
			Useful lives
	Patents and developed technologies			-1
	Purchased customer relationships			9 – 13 years
	Trademarks and trade names			-2
	Non-compete agreements			5 years
		-1	Each patent has its own legal expiration date and, therefore, its own useful life. Generally, our patents’ legal lives begin when the related patent application is filed with the relevant government authority and ends 20 years thereafter. Amortization on patent costs begins when the relevant government authority approves the related patent. Patents that have been recorded as of December 31, 2013 are expected to expire by 2033.
		-2	Trademarks and trade names of CTI are deemed to have a useful life of 15 years. CTI’s trademarks and trade names are subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon their estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.
Debt Issuance and Deferred Financing Costs	'
	Debt Issuance and Deferred Financing Costs
	Costs paid to lenders to obtain financing are presented as discounts on the related debt and are amortized to interest expense over the term of the related financing, using the effective interest method (unless the financing is a line of credit, in which case the straight-line method is used). Such costs paid to third parties are presented as assets and are amortized to interest expense in the same manner as costs paid to lenders.
Derivatives	'
	Derivatives
	Derivatives are recorded at their fair value as of the balance sheet date. If a derivative qualifies for “hedge accounting” under U.S. GAAP and has been designated as a hedge by us, then the “effectively hedged” portion is recorded, as defined by U.S. GAAP, of changes in such derivatives’ fair value in accumulated other comprehensive loss, which is a component of our stockholders’ equity. The Company records (i) ineffectively hedged portions of such changes in fair value or (ii) changes in the fair value of derivatives not designated as a hedge in our consolidated statement of comprehensive income (loss) in the period the change occurred. On the consolidated statement of cash flows, cash flows from derivative instruments accounted for as cash flow hedges are classified in the same category as the cash flows from the items being hedged.
Warrants Liability	'
	Warrants Liability
	The Company uses fair values as determined by significant unobservable inputs. These estimated values are significant inputs into the Monte Carlo simulation method and the Black Scholes pricing model used to calculate the estimated fair value of common warrants and preferred warrants potentially settleable in cash, which are recorded as warrants liability. The estimated fair value of the common warrants and the preferred warrants are determined at each balance sheet date and the change in the estimated fair value of the warrants is reflected within the Company’s statements of comprehensive loss.
Revenue Recognition	'
	Revenue Recognition
	Revenue from the sale of products or the providing of services is recognized when the earnings process is complete, the amount of recognizable revenue can be determined, the risks and rewards of ownership have transferred to the customer and collectability is reasonably assured. Depending on the terms of the individual sales arrangement with our customer, product sales are recognized at either the shipping point or upon receipt by the customer. Costs and related expenses to manufacture the products are recorded as costs of goods sold when the related revenue is recognized. Additionally, if the right of return is granted to the buyer in a product sale, revenue is deferred until enough historical customer data is available to reasonably estimate returns and related costs.
	Two significant contracts provide for the sale of indefinite quantities of products at fixed per unit prices, subject to adjustment for certain economic factors. Revenue under these contracts is recognized when products ordered under the contracts are received by the customer. Whenever costs change, the pricing under these contracts is reviewed to determine whether they require the sale of products at a loss. To date, there are no loss contracts which would require the accrual of future losses in the current financial statements.
	Research and development services are provided for customers for which the Company earns payments that are contingent upon achieving a specific result (“milestones”). Upon achieving such milestones, revenue is recognized provided that the payment is (i) related to past performance, (ii) reasonable relative to all of the deliverables and payment terms within the arrangement with our customer, and (iii) nonrefundable. In 2013 and 2012, all of such payments received met these criteria.
Taxes Collected from Customers	'
	Taxes Collected from Customers
	Sales taxes collected from customers are not considered revenue and are included in accounts payable and accrued expenses until remitted to the taxing authorities.
Shipping and Handling Costs	'
	Shipping and Handling Costs
	Outbound shipping and handling costs are included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income (loss). These costs were approximately $423,000 and $500,000 for the years ended December 31, 2013 and 2012, respectively.
Advertising Costs	'
	Advertising Costs
	Advertising costs are expensed as incurred and are included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income (loss). Advertising expense was $215,000 and $135,000 for the years ended December 31, 2013 and 2012, respectively.
Stock-Based Compensation	'
	Stock-Based Compensation
	Stock-based compensation is incurred related to awards of common stock, restricted common stock and options to employees and non-employees. Those awards are measured at their fair value on the date the award is granted and are recognized in our consolidated financial statements over the period the grantee is required to provide services in exchange for the award. When recognized as an expense, the fair value of the award, less estimated forfeitures, is recognized on a straight-line basis over the award service period; if there is no such service period, then the entire fair value of the award is recognized as expense on the grant date.
Income Taxes	'
	Income Taxes
	Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are recognized when, based upon available evidence, realization of the assets is more likely than not.
	In assessing the realization of long-term deferred income tax assets, it is considered whether it is more likely than not that the deferred income tax assets will be realized. The realization of deferred income tax assets depends upon future taxable income in years before net operating loss carryforwards expire. The recoverability of deferred income tax assets is evaluated on a quarterly basis. If the Company determines that it is more likely than not that deferred income tax assets will not be recovered, a valuation allowance is established against some or all deferred income tax assets.
	When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceeds the amount measured as described above, if such a position existed, is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. There were no such positions as of December 31, 2013 or 2012.
	Interest on tax deficiencies is classified as interest expense and income tax penalties are classified as other expense.
	In February 2012, an IRS audit was completed of the Company’s tax returns for the years 2008 and 2009. There were no adjustments to those tax returns. Tax returns filed for the fiscal years 2010, 2011, and 2012 are still open for audit.
Net Loss per Common Share	'
	Net Loss per Common Share
	Basic loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding. Diluted loss per common share is computed by dividing net loss by the weighted average number of common shares and dilutive potential common share equivalents then outstanding. Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible notes using the “if-converted” method.
			Year Ended December 31,
			2013		2012
	Basic and diluted:
	Net loss (in thousands)		$	-15,653	$	-50,218
	Accrued dividend and deemed dividend		$	-5,608	$	0
	Weighted average shares			20,714,531		18,205,586
	Loss available to common stockholders for basic and diluted loss per common share (in thousands)			-21,261		-50,218
	Basic and diluted loss per common share		$	-1.03	$	-2.76
	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented:
			Year Ended December 31,
			2013		2012
	Options and warrants			3,012,186		1,585,833
	Restricted stock awards			34,266		75,292
	Convertible notes payable			2,666,667		2,666,667
Fair Value	'
	Fair Value
	Under U.S. GAAP, the Company is required to record certain financial assets and liabilities at fair value and may choose to record other financial assets and financial liabilities at fair value as well. Also under U.S. GAAP, the Company is required to record nonfinancial assets and liabilities at fair value due to events that may or may not recur in the future, such as an impairment event. When required to record such assets and liabilities at fair value, that fair value is estimated using an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. That fair value is determined based on significant inputs contained in a fair value hierarchy as follows:
		Level 1	Quoted prices for identical assets or liabilities in active markets to which we have access at the measurement date.
		Level 2	Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
		Level 3	Unobservable inputs for the asset or liability.
	The determination of where assets and liabilities fall within this hierarchy is based upon the lowest level of input that is significant to the fair value measurement.
	There are three general valuation techniques that may be used to measure fair value, as described below:
	Market Approach	Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Prices may be indicated by pricing guides, sale transactions, market trades, or other sources.
	Cost Approach	Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost).
	Income Approach	Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about the future amounts (includes present value techniques and option-pricing models). Net present value is an income approach where a stream of expected cash flows is discounted at an appropriate market interest rate.
Recent Accounting Pronouncements	'
	Recent Accounting Pronouncements
	The following are recent accounting pronouncements that have affected our consolidated financial statements or may affect them in the future.
	In October 2012, the FASB issued Accounting Standards Update No. 2012-04, Technical Corrections and Improvements (“ASU 2012-04”), which updates a wide range of topics in the FASB Codification. ASU 2012-04 includes technical corrections and improvements to FASB Codification and conforming amendments related to fair value measurements. ASU 2012-04 was effective for fiscal periods beginning after December 15, 2012. The adoption of ASU 2012-04 did not have a material impact on our financial position or results of operations.
	In July 2013, the FASB issued Accounting Standards Update No. 2013-11, Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carry-forward, a Similar Tax Loss, or a Tax Credit Carry-forward Exists (“ASU 2013-11”) to clarify that an unrecognized tax benefit, or a portion of an unrecognized tax benefit, should be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss (“NOL”) carry-forward, a similar tax loss, or a tax credit carry-forward, with some allowed exceptions. ASU 2013-11 does not impose any new recurring disclosure requirements because it does not affect the recognition or measurement of uncertain tax positions. ASU 2013-11 is effective for fiscal years beginning after December 15, 2013. The Company believes the adoption of ASU 2013-11 will not have a material impact on our financial position or results of operations.

Significant_Accounting_Policie2

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule Of Useful Lives For Amortization Of Intangible Assets	'
	The useful lives used for amortization of intangible assets are as follows:
			Useful lives
	Patents and developed technologies			-1
	Purchased customer relationships			9 – 13 years
	Trademarks and trade names			-2
	Non-compete agreements			5 years
		-1	Each patent has its own legal expiration date and, therefore, its own useful life. Generally, our patents’ legal lives begin when the related patent application is filed with the relevant government authority and ends 20 years thereafter. Amortization on patent costs begins when the relevant government authority approves the related patent. Patents that have been recorded as of December 31, 2013 are expected to expire by 2033.
		-2	Trademarks and trade names of CTI are deemed to have a useful life of 15 years. CTI’s trademarks and trade names are subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon their estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.
Net Income Per Common Share	'
	Potential common share equivalents consist of (i) shares issuable upon the exercise of warrants and options (using the “treasury stock” method), (ii) unvested restricted stock awards (using the “treasury stock” method) and (iii) shares issuable upon conversion of convertible notes using the “if-converted” method.
			Year Ended December 31,
			2013		2012
	Basic and diluted:
	Net loss (in thousands)		$	-15,653	$	-50,218
	Accrued dividend and deemed dividend		$	-5,608	$	0
	Weighted average shares			20,714,531		18,205,586
	Loss available to common stockholders for basic and diluted loss per common share (in thousands)			-21,261		-50,218
	Basic and diluted loss per common share		$	-1.03	$	-2.76
Common Shares Issuable upon Vesting or Exercise of Convertible Securities	'
	The following potentially dilutive common share equivalents were excluded from the calculation of diluted net loss per common share because their effect was antidilutive for each of the periods presented:
			Year Ended December 31,
			2013		2012
	Options and warrants			3,012,186		1,585,833
	Restricted stock awards			34,266		75,292
	Convertible notes payable			2,666,667		2,666,667

Inventories_Tables

Inventories (Tables)	12 Months Ended
	Dec. 31, 2013
Inventory Disclosure [Abstract]	'
Schedule of Inventory	'
	Inventories, net consist of the following (all amounts in thousands):
		2013		2012
	Raw materials	$	6,535	$	6,255
	Work-in-process		2,185		1,530
	Finished goods		2,062		1,812
		$	10,782	$	9,597

Prepaid_Expenses_And_Other_Cur1

Prepaid Expenses And Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Prepaid Expense and Other Assets, Current [Abstract]	'
Schedule Of Prepaid Expenses and Other Current Assets	'
	Prepaid expenses and other current assets consist of the following (all amounts in thousands):
		2013		2012
	Value added taxes receivable	$	17	$	53
	Franchise taxes receivable		0		32
	Prepaid expenses		312		322
	Debt issuance costs, current portion		53		136
	Other		81		15
		$	463	$	558

Property_Plant_And_Equipment_T

Property, Plant And Equipment (Tables)	12 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Schedule of Property, Plant and Equipment	'
	Property, plant and equipment consist of the following (all amounts in thousands):
		2013		2012
	Land	$	1,285	$	1,904
	Building and improvements		3,332		3,256
	Machinery and equipment		8,300		7,905
	Leasehold improvements		266		0
	Furniture and fixtures		122		69
	Software		59		0
			13,364		13,134
	Less: accumulated depreciation and amortization		-5,363		-3,957
		$	8,001	$	9,177

Goodwill_Tables

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill, Impaired [Abstract]	'
Schedule of Goodwill	'
	Changes in the carrying amount of goodwill consist of the following (all amounts in thousands):
				CTI/CTSAS						Total Consolidated
				Chemical Light		CTS Training	CPS			Goodwill
	Balance on December 31, 2011 (1)		$	51,244	$	1,107	$	2,978	$	55,329
	Impairment loss (see Notes 3 and 23)			-46,230		-858		0		-47,088
	Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets			0		-183		0		-183
	Finalization of the fair value determination of contingent consideration in the CTS acquisition (2)			0		166		0		166
	Finalization of the CTS acquisition-related deferred tax liability (2)			0		-64		0		-64
	Balance on December 31, 2012 (3)			5,014		168	$	2,978		8,160
	Impairment loss (see Notes 3 and 23)			0		-168		0		-168
	Balance on December 31, 2013 (4)		$	5,014	$	0	$	2,978	$	7,992
		-1	Gross amount of goodwill was approximately $67.8 million as of December 31, 2011. Accumulated impairment losses were $12.5 million as of December 31, 2011.
		-2	On December 22, 2011, CTI entered into a Stock Purchase Agreement (“SPA”) with CTS and the sole stockholder of CTS. A portion of the consideration paid to the sellers of CTS is contingent upon the financial performance of the acquired business during the combined calendar years 2012 and 2013. The initial accounting for that contingent consideration liability was not complete as of December 31, 2011 since the fair value determination of that liability had not yet been finalized. The finalization of this accounting during 2012 resulted in a $166,000 increase in both CTS’ goodwill asset and contingent consideration liability. Additionally, the initial accounting for the CTS acquisition-related deferred tax liability had not yet been finalized as of December 31, 2011. The finalization of this accounting during 2012 resulted in a $64,000 decrease in both CTS’s goodwill asset and deferred tax liability.
		-3	Gross amount of goodwill was approximately $67.7 million as of December 31, 2012. Accumulated impairment losses were approximately $59.5 million as of December 31, 2012.
		-4	Gross amount of goodwill was approximately $67.7 million as of December 31, 2013. Accumulated impairment losses were approximately $59.7 million as of December 31, 2013.

Other_Intangible_Assets_Tables

Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Finite-Lived Intangible Assets	'
	Intangible assets as of December 31, 2013 consist of the following (all amounts in thousands):
			Cost		Accumulated		Net Book Value
					Amortization
	Developed technologies, including patents (1)		$	13,853	$	5,720	$	8,133
	Trademarks and trade names			5,365		119		5,246
	Purchased customer relationships (2)			8,812		4,336		4,476
	Non-compete agreements (3)			160		75		85
	Website development costs			8		0		8
			$	28,198	$	10,250	$	17,948
		-1	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 were impaired by approximately $221,000 during 2013 (see Note 3 Impairment Charges) and the $17,000 of CTS patents remaining after the impairment is expected to be fully amortized in December 2021.
		-2	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Customer relationships obtained in the acquisition of CTS with a cost of $840,000 was impaired by approximately $780,000 (see Note 3 Impairment Charges) and the $60,000 of CTS customer relationships remaining after the impairment is expected to be fully amortized in December 2021.
		-3	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 was determined to be fully impaired in 2013 (see Note 3 Impairment Charges).
	Intangible assets as of December 31, 2012 consist of the following (all amounts in thousands):
			Cost		Accumulated		Net Book Value
					Amortization
	Developed technologies, including patents (1)		$	13,730	$	4,755	$	8,975
	Trademarks and trade names (2)			5,401		37		5,364
	Purchased customer relationships (3)			9,507		3,811		5,696
	Non-compete agreements (4)			220		65		155
			$	28,858	$	8,668	$	20,190
		-1	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Also includes patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 (see Note 3 Impairment Charges).
		-2	Includes a trade name obtained in the acquisition of CTS with an initial cost of $90,000 (see Note 3 Impairment Charges).
		-3	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Also includes customer relationships obtained in the acquisition of CTS with a cost of $840,000 (see Note 3 Impairment Charges).
		-4	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Also includes non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 (see Note 3 Impairment Charges).
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	The future amortization expense relating to finite-lived intangible assets for the next five years and beyond is estimated at December 31, 2013 to be (all amounts in thousands):
	Year Ending December 31,
	2014		$	1,970
	2015			1,970
	2016			1,959
	2017			1,927
	2018			1,889
	Thereafter			7,011
			$	16,726

Accrued_Expenses_Tables

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2013
Payables and Accruals [Abstract]	'
Schedule of Accrued Liabilities	'
	Accrued expenses consist of the following (all amounts in thousands):
			2013		2012
	Payroll-related (1)		$	1,145	$	1,817
	Interest			331		143
	Professional fees			26		178
	Related party payable – Selway Capital, LLC (2)			158		32
	Other			399		413
			$	2,059	$	2,583
		-1	Accrued payroll-related costs as of December 31, 2013 include approximately $534,000 of accrued severance costs. Accrued payroll-related costs as of December 31, 2012 include approximately $296,000 of accrued severance costs.
		-2	See Note 18 for a description of the agreement with Selway Capital, LLC.

Notes_Payable_Tables

Notes Payable (Tables)	12 Months Ended
	Dec. 31, 2013
Notes Payable [Abstract]	'
Schedule of Debt	'
	Outstanding notes payable consist of (all amounts in thousands):
		2013		2012
	Senior Debt - Term Loan	$	6,023	$	8,519
	Senior Debt - Real Estate Loan		1,679		1,804
	Subordinated Term Loan		8,659		8,500
	Promissory Note Payable		1,075		0
	Total		17,436		18,823
	Less: Unamortized debt discount		-542		-695
	Less: Current portion of notes payable, including current portion of unamortized debt discount		-1,925		-9,734
	Notes payable, net of current portion	$	14,969	$	8,394
Schedule Of Carrying Value Of The Subordinated Term Loan	'
	The carrying value of the Subordinated Term Loan is as follows (all amounts in thousands):
		2013		2012
	Principal amount of loan	$	8,659	$	8,500
	Less: unamortized debt discount		-424		-622
		$	8,235	$	7,878
Schedule Of Interest Costs Of The Subordinated Term Loan	'
	Interest costs for the Subordinated Term Loan are as follows (all amounts in thousands):
		2013		2012
	Contractual interest coupon rate	$	949	$	951
	Amortization of related debt discount and debt issuance costs		486		308
	Total interest expense recognized	$	1,435	$	1,259
Schedule of Contractual Obligation, Fiscal Year Maturity	'
	As of December 31, 2013, future minimum payments due for notes payable (excluding the related party Amended JFC Note as discussed in Note 13) for each of the five succeeding years and beyond are as follows (all amounts in thousands):
	Year Ending December 31,
	2014	$	2,116
	2015		6,016
	2016		8,874
	2017		215
	2018		215
	Thereafter		0
		$	17,436

Capital_Lease_Obligations_Tabl

Capital Lease Obligations (Tables)	12 Months Ended
	Dec. 31, 2013
Leases [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases	'
	As of December 31, 2013, future minimum lease payments under capital leases together with the present value of the net minimum lease payments were as follows (all amounts in thousands):
	Year Ending December 31,
	2014	$	17
	2015		7
	2016		0
	2017		0
	2018		0
	Thereafter		0
	Total minimum lease payments		24
	Less: amount representing interest		-2
	Present value of net minimum lease payments	$	22

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Income before Income Tax, Domestic and Foreign	'
	The components of income (loss) before income taxes are as follows:
			Year Ended December 31,
			2013		2012
	Domestic		$	-18,866	$	-54,153
	Foreign			175		966
			$	-18,691	$	-53,187
Schedule of Components of Income Tax Expense (Benefit)	'
	Benefit from income taxes consisted of the following (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Current:
	Federal		$	0	$	0
	State			160		0
	Foreign			130		388
	Deferred:
	Federal			-2,678		-2,556
	State			-595		-738
	Foreign			-55		-63
	Benefit from income taxes		$	-3,038	$	-2,969
Schedule of Deferred Tax Assets and Liabilities	'
	Deferred income tax assets and liabilities consist of the following (all amounts in thousands):
			December 31, 2013				December 31, 2012
			Current		Non-current		Current		Non-current
	Deferred tax assets:
	Federal		$	6,329	$	7,230	$	1,390	$	8,256
	State			886		868		563		786
	Foreign			34		20		36		16
	Less: valuation allowance			-2,747		-3,175		-689		-3,185
				4,502		4,943		1,300		5,873
	Deferred tax liabilities:
	Federal			-477		-6,615		-469		-7,311
	State			-124		-1,697		-122		-1,886
	Foreign			-54		-478		-57		-538
				-655		-8,790		-648		-9,735
	Deferred tax assets (liabilities)		$	3,847	$	-3,847	$	652	$	-3,862
	Principal components of our net asset representing deferred income tax balances are as follows (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Intangible assets		$	-3,778	$	-3,408
	Property, plant and equipment			-740		-752
	U.S. loss carryforwards and tax credits, net (1)			8974		4,703
	Subsidiary income (2)			-1,671		-1,459
	Stock-based compensation expense			968		725
	Reserves, accruals and other			1,292		805
	Change in warrants fair value			877		0
	Valuation allowance			-5,922		-3,874
	Interest rate swaps			0		50
			$	0	$	-3,210
		-1	The Company had federal net operating loss carryforwards amounting to approximately $13.3 million and $2.0 million at December 31, 2013 and 2012, respectively. The net operating loss carryforward at December 31, 2013 expires in fiscal years 2025 through 2033. Internal Revenue Code Section 382 limits utilization of these losses to $3.2 million per year. It is possible that future changes in ownership could result in changes to the amounts allowed by IRC Section 382. State net operating loss carryforwards amounted to approximately $2.0 million and $1.0 million as of December 31, 2013 and 2012, respectively.
		-2	A deferred tax liability has been recorded for income taxes which may become payable upon distribution of earnings of CTSAS, our French subsidiary. The estimated amount of tax that might be payable with regard to any distribution for foreign subsidiary earnings is reported net of foreign taxes paid, which are creditable against our domestic tax liability. We do not permanently reinvest our foreign subsidiary’s earnings. The Company continually evaluates our assertion; if our foreign business needs change, so may our assertion.
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	'
	Income taxes computed using the federal statutory income tax rate differs from our effective tax rate primarily due to the following (all amounts in thousands):
			Year Ended December 31,
			2013		2012
	Provision for federal income taxes expected at 34% statutory rate		$	-6,355	$	-18,083
	Increase (reduction) resulting from:
	Tax on global activities			2		38
	State income taxes, less federal income tax benefit			-287		-518
	Exempt interest			728		0
	Change in valuation allowance			3,507		0
	Goodwill impairment loss			57		15,615
	Prior year true up			-715		-33
	Other			25		12
	Benefit from income taxes		$	-3,038	$	-2,969

Derivative_Instruments_And_Hed1

Derivative Instruments And Hedging Activities (Tables)	12 Months Ended
	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosure [Abstract]	'
Derivative Liabilities in Condensed Consolidated Balance Sheet	'
	Derivatives held by us as of December 31, 2013 consist of the following (all amounts in thousands):
	Derivative Instrument		Balance Sheet Location		Fair Value
	Currency forward contracts		Derivatives liability (current liabilities)		$	0
	Interest rate swaps		Derivatives liability (current liabilities)			0
	Derivatives held by us as of December 31, 2012 consist of the following (all amounts in thousands):
	Derivative Instrument		Balance Sheet Location		Fair Value
	Currency forward contracts		Prepaid expenses and other current assets		$	-14
	Interest rate swaps		Derivatives liability (noncurrent liabilities)			-155
Effect of Derivative Instruments Designated as Cash Flow Hedges and Not Designated as Hedging Instruments on Condensed Consolidated Statement of Income	'
	The effect of derivative instruments (a) designated as cash flow hedges and (b) not designated as hedging instruments on our consolidated statement of comprehensive loss for year ended December 31, 2013 was as follows (all amounts in thousands):
			Gain (Loss)			Gain (Loss)		Gain (Loss)
			In AOCL (1)			Reclassified (2)		in Earnings (3)
	Derivatives designated as cash flow hedges:
	Interest rate swaps, net of taxes of $(59)		$	97		$	0	$	0
	Derivatives not designated as hedging instruments:
	Currency forward contracts		$	0		$	0	$	0
		-1	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2013.
		-2	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2013.
		-3	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2013.
	The effect of derivative instruments (a) designated as cash flow hedges and (b) not designated as hedging instruments on our consolidated statement of comprehensive loss for year ended December 31, 2012 was as follows (all amounts in thousands):
			Gain (Loss)			Gain (Loss)		Gain (Loss)
			In AOCL (1)			Reclassified (2)		in Earnings (3)
	Derivatives designated as cash flow hedges:
	Interest rate swaps, net of taxes of $(45)		$	73		$	0	$	0
	Derivatives not designated as hedging instruments:
	Currency forward contracts		$	0		$	0	$	-18
		-1	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2012.
		-2	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2012.
		-3	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2012.

Asset_Retirement_Obligation_Ta

Asset Retirement Obligation (Tables)	12 Months Ended
	Dec. 31, 2013
Asset Retirement Obligation Disclosure [Abstract]	'
Schedule Of Significant Assumptions Used To Estimate The Obligation	'
	The Company has an obligation to remediate certain known occurrences of asbestos at our manufacturing facility in West Springfield, Massachusetts. The significant assumptions used to estimate the obligation are:
	Annual inflation rate		5.54	%
	Credit-adjusted risk-free rate		5.37	%
	Initial estimated remediation costs (undiscounted and not adjusted for inflation)		$200,000 ($41,000 paid in 2007)
	Estimated remediation completion date		19-Dec-38
	Estimated remediation cost on December 19, 2038	$	720,000
Schedule of Change in Asset Retirement Obligation	'
	The following is a reconciliation of the beginning and ending aggregate carrying amounts of the asset retirement obligation for the years ended December 31, 2013 and 2012 (all amounts in thousands):
		Year Ended December 31,
		2013			2012
	Balance, beginning	$	184		$	175
	Accretion expense		10			9
	Balance, ending	$	194	-1	$	184

Commitments_And_Contingencies_

Commitments And Contingencies (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Schedule of Future Minimum Rental Payments for Operating Leases	'
	Future minimum lease payments under non-cancelable lease obligations at December 31, 2013 are as follows (all amounts in thousands):
	Year Ending December 31,
	2014	$	687
	2015		628
	2016		483
	2017		238
	2018		59
	Thereafter		0
		$	2,095

Preferred_Stock_Tables

Preferred Stock (Tables)	12 Months Ended
	Dec. 31, 2013
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract]	'
Schedule Of Common And Preferred Warrants	'
	The fair value as of December 31, 2013 of the Common Warrant is estimated using the Monte Carlo simulation method with the following inputs:
		Common Warrant
	Stock price of underlying equity	$	0.69
	Exercise price	$	0.65
	Expected volatility (standard deviation)		100	%
	Annual risk-free rate		3.04	%
	Expected term (time to expiration years)		9.9
	Number of periods		514
	Period interval		0.019
	Period risk-free rate		0.058	%
	Number of simulations		500,000
	The fair value as December 31, 2013 of the Preferred Warrant is estimated using the Black-Scholes pricing model with the following inputs:
		Preferred Warrant
	Stock price of underlying equity	$	32.5
	Exercise price	$	0.05
	Expected term (years)		1.7
	Risk-free interest rate		0.13	%
	Estimated dividend yield		None
	Volatility		70	%
Schedule Of Change In The Fair Value Of The Warrants Liability	'
	The change in the fair value of the warrants liability during the year ended December 31, 2013 is as follows (amounts in thousands):
		Common			Preferred		JFC Warrant		Subordinated Term Loan Warrants		Total Warrant
		Warrant			Warrant		(see Note 13)		(see Note 12)		Liability
	Warrant liability at December 31, 2012	$	0		$	0	$	0	$	0	$	0
	Fair value recorded on the November 19, 2013 transaction date		3,556			1,997		54		241		5,848
	Change in fair value of warrants		525			0		0		0		525
	Warrant liability at December 31, 2013	$	4,081		$	1,997	$	54	$	241	$	6,373

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2013
Stockholders' Equity Note [Abstract]	'
Schedule of Stockholders Equity Note, Warrants or Rights	'
	Warrants to purchase the Company’s common stock were outstanding as follows as of December 31, 2013:
	Warrant Holder		Number of			Exercise			Expiration Date
			Shares			Price
			Exercisable
			Under Warrant
	US VC Partners, L.P.			6,153,850		$	0.65		19-Nov-23
	JFC Technologies LLC			73,009			0.01		19-Nov-23
	Granite Creek FlexCap I, L.P.			267,950			0.01		19-Nov-23
	Patriot Capital II, L.P.			187,564			0.01		19-Nov-23
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	'
	The following presents how share-based expenses are included in our consolidated statements of comprehensive loss (in thousands):
			Year Ended December 31,
			2013			2012
	Cost of revenues		$	9		$	12
	Sales and marketing			44			-12
	General and administrative			621			387
	Research and development			99			116
			$	773		$	503
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	'
	The fair value of each award is estimated on the date of grant using the Black-Scholes pricing model with the following assumptions for awards to employees and non-employees:
			2013				2012
	Expected term (years)			5.0 – 6.5				5.0 – 6.5
	Risk-free interest rate			1.10 – 1.70	%			.73 – 1.43	%
	Estimated dividend yield			None				None
	Volatility			126.71 – 130.08	%			26.45 – 128.16	%
Schedule of Share-based Compensation, Stock Options, Activity	'
	Stock option and warrant activity related to share-based compensation is summarized as follows:
			Shares			Weighted Average
			(in thousands)			Exercise Price
	Outstanding at December 31, 2011			1,166			3.44
	Granted (1)			1,708			1.6
	Exercised (2)			-5			3.65
	Forfeited			-24			3.71
	Expired			-3			3.8
	Outstanding at December 31, 2012			2,842			2.33
	Granted (3)			708			1.79
	Exercised			0			-
	Forfeited			-255			2.02
	Expired			-283			3.78
	Outstanding at December 31, 2013			3,012			2.09
	Exercisable at December 31, 2013			1,321		$	2.76
		-1	The weighted-average grant-date fair value of awards granted was $1.33.
		-2	The intrinsic value of awards exercised was $1,000. These options were exercised on a cashless basis, therefore no cash was received at exercise. The tax benefit realized from this exercise was insignificant.
		-3	The weighted-average grant-date fair value of awards granted was $1.61.
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable	'
	The following table summarizes information about stock options and warrants related to stock-based compensation that (i) are not subject to performance conditions and (ii) are vested or are expected to vest as of December 31, 2013:
										Options Outstanding				Options Exercisable
										Weighted
										Average		Weighted						Weighted
							Number			Remaining		Average		Number				Average
	Range of						Outstanding			Contractual		Exercise		Exercisable				Exercise
	Exercise Prices						(in thousands)			Term (Years)		Price		(in thousands)				Price
	$	0		$	2			2,212			8.3	$	1.57		545		$	1.69
		2.01			4			675			6.18		3.34		668			3.33
		4.01			6			125			6.94		4.61		108			4.61
								3,012	-1		7.77	$	2.09		1,321	-2	$	2.76
		-1	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013.
		-2	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013. The weighted-average remaining contractual term for these options is 6.45 years as of December 31, 2013.
Schedule of Nonvested Restricted Stock Units Activity	'
	Nonvested restricted common stock related to stock-based compensation is summarized as follows:
				Shares			Weighted
				(in thousands)			Average Grant
							Date Fair Value
	Outstanding at December 31, 2011			277				3.88
	Granted			29				2.66
	Vested (1)			-129				3.53
	Forfeited			-141				3.98
	Outstanding at December 31, 2012			36	-3		$	3.76
	Granted			0				-
	Vested (2)			-36				3.76
	Forfeited			0				-
	Outstanding at December 31, 2013			0			$	-
		-1	The total fair value of restricted common stock awards that vested during 2012 was $364,000.
		-2	The total fair value of restricted common stock awards that vested during 2013 was $45,000.
		-3	These stock awards vested upon fulfilling service conditions.
Schedule of Accumulated Other Comprehensive Income (Loss)	'
	The ending accumulated balances for each item in accumulated other comprehensive loss are as follows (all amounts in thousands):
			Year Ended December 31,
			2013			2012
	Foreign currency translation loss		$	-218		$	-418
	Unrealized gain on cash flow hedges, net of taxes			0			-97
			$	-218		$	-515
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	'
	Changes in accumulated other comprehensive loss due to derivative instruments and hedging activities are as follows (all amounts in thousands):
	Balance, December 31, 2011		$	-170
	Unrealized gain on interest rate swaps, net of taxes of $(45)			73
	Balance, December 31, 2012			-97
	Unrealized gain on cash flow hedges, net of taxes of $(59)			97
	Balance, December 31, 2013		$	0
Schedule Of Foreign Currency Translation Adjustment In Accumulated Other Comprehensive Income (Loss)	'
	Changes in accumulated other comprehensive loss due to currency translation adjustments (all amounts in thousands):
	Balance, December 31, 2011		$	-526
	Adjustments due to translation of CTSAS financial statements from Euros into U.S. Dollars			108
	Balance, December 31, 2012			-418
	Adjustments due to translation of CTSAS financial statements from Euros into U.S. Dollars			200
	Balance, December 31, 2013		$	-218

Fair_Values_of_Assets_And_Liab1

Fair Values of Assets And Liabilities (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Disclosures [Abstract]	'
Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2013:
			Level 1
			Quoted
			Prices in
			Active			Level 2
			Markets			Significant			Level 3		Assets/
			for			Other			Significant		(Liabilities)
			Identical			Observable			Unobservable		At Fair
			Assets			Inputs			Inputs		Value
	Interest rate swaps (see Note 16) (1)		$	0		$	0			0	$	0
	Currency forward contracts (see Note 16) (2)			0			0			0		0
	Warrants (see Note 19)(3)			0			0			-6,373		-6,373
			$	0		$	0		$	-6,373	$	-6,373
		-1	The fair values of the swaps are determined by discounting the estimated cash flows to be received and paid due to the swaps over the swap’s contractual lives using an estimated risk-free interest rate for each swap settlement date (an income approach).
		-2	The fair value of these contracts is determined by multiplying the notional amount of the contract by the difference between (a) the U.S. dollar amount due on the contract at maturity and (b) the foreign exchange rate as of the date the contract is valued (the balance sheet date). Because the contracts typically have a short duration, the value is not discounted using a present value technique (an income approach).
		-3	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.
	Assets and liabilities itemized below were measured at fair value on a recurring basis at December 31, 2012:
			Level 1
			Quoted
			Prices in
			Active			Level 2
			Markets			Significant			Level 3		Assets/
			for			Other			Significant		(Liabilities)
			Identical			Observable			Unobservable		At Fair
			Assets			Inputs			Inputs		Value
	Interest rate swaps (see Note 16) (1)			0		$	-155			0	$	-155
	Currency forward contracts (see Note 16) (2)			0			-14			0		-14
			$	0		$	-169		$	0	$	-169
		-1	The fair values of the swaps are determined by discounting the estimated cash flows to be received and paid due to the swaps over the swap’s contractual lives using an estimated risk-free interest rate for each swap settlement date (an income approach).
		-2	The fair value of these contracts is determined by multiplying the notional amount of the contract by the difference between (a) the U.S. dollar amount due on the contract at maturity and (b) the foreign exchange rate as of the date the contract is valued (the balance sheet date). Because the contracts typically have a short duration, the value is not discounted using a present value technique (an income approach).
Reconciliation of Contingent Consideration Liability Measured at Fair Value on Recurring Basis Using Significant Unobservable Inputs	'
	The tables below presents reconciliations for all assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2013 and 2012:
			Year Ended December 31,
			2013			2012
	Warrants liability:
	Balance at the beginning of period		$	0		$	0
	Fair value recorded on the November 19, 2013 transaction date			5,848			0
	Change in fair value of warrants			525			0
	Balance at the end of period		$	6,373		$	0
			Year Ended December 31,
			2013			2012
	Contingent consideration:
	Balance at the beginning of period		$	0		$	-3,699
	Initial recognition of the liabilities			0			0
	Unrealized gains (losses) in earnings			0			-3,380
	Finalization of the fair value determination of contingent consideration in the CTS acquisition			0			-166
	Payment of contingent consideration from the CSP acquisition			0			7,245
	Balance at the end of period		$	0		$	0
Assets and Liabilities Measured at Fair Value on Non-Recurring Basis	'
	Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis
	During the year ended December 31, 2013, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see also Note 3):
			Cyalume Reporting Unit (1)		Loss Recognized			Fair Value
	Goodwill (2)		CTS Training		$	168		$	0
	Patents (3)		CTS Training			174			17
	Trade name (4)		CTS Training			17			0
	Non-compete agreements (5)		CTS Training			34			0
	Customer Relationships		CTS Training			650			60
	During the year ended December 31, 2012, the following assets, all of which are Level 3 assets, were identified as impaired and were adjusted to their fair values (in thousands of dollars) (see also Note 3):
			Cyalume Reporting Unit (1)		Loss Recognized			Fair Value
	Goodwill (2)		Chemical Light		$	46,230		$	5,014
	Goodwill (2)		Training			858			351
	Patents (3)		Training			172			210
	Trade name (4)		Training			29			30
	Non-compete agreements (5)		Training			80			40
	Certain equipment (6)		Chemical Light			273			0
		-1	The Company managed as one operating segment with four reporting units: Chemical Light (the operations of CTI and CTSAS), CTS Training (the operations of CTS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Specialty Products’ goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
		-2	The fair value of the impaired goodwill asset was determined calculating the excess of the fair value of the reporting unit over the fair values assigned to its assets and liabilities and utilized present value techniques utilizing each reporting unit’s forecasted after-tax cash flows.
		-3	The fair value of the impaired patent asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).
		-4	The fair value of the impaired trademarks and trade names asset was determined using the “relief from royalty” method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).
		-5	The fair value of the impaired non-compete agreement asset was determined using the “comparative business valuation” method, which compares the present value of two streams of the reporting unit’s estimated future cash flows; one stream assuming the non-compete agreements are in place and the other stream assuming the agreements are not in place (an income approach).
		-6	The fair value of the impaired equipment was determined estimating the present value of cash flows expected to result from the use and disposition of the equipment (an income approach).

Supplemental_Disclosure_of_Cas1

Supplemental Disclosure of Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2013
Supplemental Cash Flow Elements [Abstract]	'
Cash Paid for Interest and Income Taxes	'
	Cash Paid for Interest and Income Taxes (all amounts in thousands):
		Year Ended December 31,
		2013		2012
	Interest	$	1,693	$	1,762
	Income taxes		133		554
Non-Cash Investing and Financing Activities	'
	Non-Cash Investing and Financing Activities (all amounts in thousands):
		Year Ended December 31,
		2013		2012
	Series A Convertible Preferred stock in-kind dividend	$	55	$	0
	Series A Convertible Preferred stock deemed dividend		4,000		0
	Warrants liability recorded in connection with common and preferred warrants		5,607		0
	Amendment and adjustment to the fair value of warrants issued in conjunction with issuance of subordinated term loan recorded within warrant liability		241		94
	Adjustment to goodwill acquired and contingent consideration incurred in the acquisition of CTS due to the finalization of the fair value of the contingent consideration		0		166
	Adjustment to goodwill acquired and deferred tax liability incurred in the acquisition of CTS due to the finalization of the fair value of the business combination		0		64
	Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets		0		183
	Issuance of 2,450,000 shares of our common stock to repay the contingent consideration liability resulting from the acquisition of CSP		0		5,145
	Issuance of a $2,100,000 note payable to repay the contingent consideration liability resulting from the acquisition of CSP		0		2,100
	Issuance of 22,500 shares of our common stock to settle litigation claim		0		56

Recovered_Sheet1

Background and Description of Business - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net Income (Loss) Attributable To Parent	($15,653,000)	($50,218,000)	'
Net Cash Provided By Used In Operating Activities	-2,607,000	3,500,000	'
Retained Earnings Accumulated Deficit	-95,874,000	-80,221,000	'
Cash	865,000	2,695,000	2,951,000
Stockholders Equity	6,504,000	25,275,000	69,653,000
Loss Contingency Accrual, Beginning Balance	$4,000,000	'	'

Significant_Accounting_Policie3

Significant Accounting Policies (Useful Lives Used For Amortization Of Intangible Assets) (Detail)	12 Months Ended
	Dec. 31, 2013
Intangible Assets Useful Life [Line Items]	'
Useful lives	'20 years
Patented Technology [Member] | Minimum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'0 years	[1]
Patented Technology [Member] | Maximum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'20 years	[1]
Customer Relationships [Member] | Minimum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'9 years
Customer Relationships [Member] | Maximum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'13 years
Trademarks and Trade Names [Member] | Minimum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'0 years	[2]
Trademarks and Trade Names [Member] | Maximum [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'15 years	[2]
Noncompete Agreements [Member]	'
Intangible Assets Useful Life [Line Items]	'
Useful lives	'5 years
[1]	Each patent has its own legal expiration date and, therefore, its own useful life. Generally, our patentsb legal lives begin when the related patent application is filed with the relevant government authority and ends 20 years thereafter. Amortization on patent costs begins when the relevant government authority approves the related patent. Patents that have been recorded as of December 31, 2013 are expected to expire by 2033.
[2]	Trademarks and trade names of CTI are deemed to have a useful life of 15 years. CTIbs trademarks and trade names are subject to annual impairment reviews as of August 31, and, if conditions warrant, interim reviews based upon their estimated fair value. Impairment charges, if any, are recorded in the period in which the impairment is determined.

Significant_Accounting_Policie4

Significant Accounting Policies (Net Income (Loss) Per Common Share) (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Basic and diluted:	'	'
Net loss (in thousands)	($15,653)	($50,218)
Accrued dividend and deemed dividend	-5,608	0
Weighted average shares	20,714,531	18,205,586
Loss available to common stockholders for basic and diluted loss per common share (in thousands)	($21,261)	($50,218)
Basic and diluted loss per common share	($1.03)	($2.76)

Significant_Accounting_Policie5

Significant Accounting Policies (Dilutive Common Share Equivalents Were Excluded From The Calculation Of Diluted Net Income Per Common Share) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Options and warrants [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Shares excluded from the calculation of diluted net income per common share	3,012,186	1,585,833
Restricted stock awards [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Shares excluded from the calculation of diluted net income per common share	34,266	75,292
Convertible notes payable [Member]	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'
Shares excluded from the calculation of diluted net income per common share	2,666,667	2,666,667

Significant_Accounting_Policie6

Significant Accounting Policies (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Significant Accounting Policies [Line Items]	'	'
Shipping, Handling and Transportation Costs	$423,000	$500,000
Advertising Expense	$215,000	$135,000
Equipment [Member] | Maximum [Member]	'	'
Significant Accounting Policies [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'8 years	'
Equipment [Member] | Minimum [Member]	'	'
Significant Accounting Policies [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'4 years	'
Building Improvements [Member]	'	'
Significant Accounting Policies [Line Items]	'	'
Property, Plant and Equipment, Useful Life	'30 years	'

Impairment_Charges_Additional_

Impairment Charges (Additional Information) (Detail) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Aug. 31, 2012

Jun. 30, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Customer Relationships [Member]

Customer Relationships [Member]

Chemical Light [Member]

Patents [Member]

Patents [Member]

Trademarks and Trade Names [Member]

Trademarks and Trade Names [Member]

Non Compete Agreement [Member]

Non Compete Agreement [Member]

Asset Impairment Charges [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Share Price

'

'

$2.34

'

'

'

'

'

'

'

'

'

Impairment loss (see Notes 3 and 23)

$168,000

$47,088,000

'

'

'

'

'

'

'

'

'

'

Impairment loss on intangible assets

875,000

281,000

'

875

650,000

'

174,000

172,000

17,000

29,000

34,000

80,000

Impairment loss on equipment

$0

$273,000

'

'

'

$273,000

'

'

'

'

'

'

Inventories_Schedule_Of_Invent

Inventories (Schedule Of Inventories) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule of Inventory [Line Items]	'	'
Raw materials	$6,535	$6,255
Work-in-process	2,185	1,530
Finished goods	2,062	1,812
Inventory, Gross, Total	$10,782	$9,597

Prepaid_Expenses_And_Other_Cur2

Prepaid Expenses And Other Current Assets (Schedule Of Prepaid Expenses And Other Current Assets) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Value added taxes receivable	$17	$53
Franchise taxes receivable	0	32
Prepaid expenses	312	322
Debt issuance costs, current portion	53	136
Other	81	15
Prepaid expenses and other current assets total	$463	$558

Property_Plant_And_Equipment_S

Property, Plant And Equipment (Schedule Of Property Plant And Equipment) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Land	$1,285	$1,904
Building and improvements	3,332	3,256
Machinery and equipment	8,300	7,905
Leasehold improvements	266	0
Furniture and fixtures	122	69
Software	59	0
Property, Plant and Equipment, Gross	13,364	13,134
Less: accumulated depreciation and amortization	-5,363	-3,957
Property, Plant and Equipment, Net	$8,001	$9,177

Property_Plant_And_Equipment_A

Property, Plant And Equipment (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Line Items]	'	'
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation	$20,000	$9,000
Capital Leases, Income Statement, Depreciation Expense	11,000	9,000
Machinery and Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Capital Lease Obligations	$77,000	$77,000

Goodwill_Schedule_Of_Goodwill_

Goodwill (Schedule Of Goodwill, Impairment Loss) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Goodwill [Line Items]	'		'
Beginning balance	$8,160	[1]	$55,329	[2]
Impairment loss (see Notes 3 and 23)	-168		-47,088
Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets	0		183
Finalization of the fair value determination of contingent consideration in the CTS acquisition	'		166	[3]
Finalization of the CTS acquisition-related deferred tax liability	'		-64	[3]
Ending balance	7,992	[4]	8,160	[1]
Cyalume Specialty Products Inc [Member]	'		'
Goodwill [Line Items]	'		'
Beginning balance	5,014	[1]	51,244	[2]
Impairment loss (see Notes 3 and 23)	0		-46,230
Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets	'		0
Finalization of the fair value determination of contingent consideration in the CTS acquisition	'		0	[3]
Finalization of the CTS acquisition-related deferred tax liability	'		0	[3]
Ending balance	5,014	[4]	5,014	[1]
Combat Training Solutions Inc. [Member]	'		'
Goodwill [Line Items]	'		'
Beginning balance	168	[1]	1,107	[2]
Impairment loss (see Notes 3 and 23)	-168		-858
Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets	'		-183
Finalization of the fair value determination of contingent consideration in the CTS acquisition	'		166	[3]
Finalization of the CTS acquisition-related deferred tax liability	'		-64	[3]
Ending balance	0	[4]	168	[1]
CPS [Member]	'		'
Goodwill [Line Items]	'		'
Beginning balance	2,978	[1]	2,978	[2]
Impairment loss (see Notes 3 and 23)	0		0
Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets	'		0
Finalization of the fair value determination of contingent consideration in the CTS acquisition	'		0	[3]
Finalization of the CTS acquisition-related deferred tax liability	'		0	[3]
Ending balance	$2,978	[4]	$2,978	[1]
[1]	Gross amount of goodwill was approximately $67.7 million as of December 31, 2012. Accumulated impairment losses were approximately $59.5 million as of December 31, 2012.
[2]	Gross amount of goodwill was approximately $67.8 million as of December 31, 2011. Accumulated impairment losses were $12.5 million as of December 31, 2011.
[3]	On December 22, 2011, CTI entered into a Stock Purchase Agreement (bSPAb) with CTS and the sole stockholder of CTS. A portion of the consideration paid to the sellers of CTS is contingent upon the financial performance of the acquired business during the combined calendar years 2012 and 2013. The initial accounting for that contingent consideration liability was not complete as of December 31, 2011 since the fair value determination of that liability had not yet been finalized. The finalization of this accounting during 2012 resulted in a $166,000 increase in both CTSb goodwill asset and contingent consideration liability. Additionally, the initial accounting for the CTS acquisition-related deferred tax liability had not yet been finalized as of December 31, 2011. The finalization of this accounting during 2012 resulted in a $64,000 decrease in both CTSbs goodwill asset and deferred tax liability.
[4]	Gross amount of goodwill was approximately $67.7 million as of December 31, 2013. Accumulated impairment losses were approximately $59.7 million as of December 31, 2013.

Goodwill_Additional_Informatio

Goodwill (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2011
Goodwill, Gross	$67,700,000	$67,700,000	$67,800,000
Goodwill, Impaired, Accumulated Impairment Loss	59,500,000	59,700,000	12,500,000
Increase In Goodwill Asset and Contingent Liability	166,000	'	'
Decrease In Goodwill Asset and Deferred Tax Liability	$64,000	'	'

Other_Intangible_Assets_Schedu

Other Intangible Assets (Schedule Of Showing Of Components Of Other Intangible Assets) (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	$28,198		$28,858
Accumulated Amortization	10,250		8,668
Net Book Value	17,948		20,190
Developed Technologies Including Patents [Member]	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	13,853	[1]	13,730	[2]
Accumulated Amortization	5,720	[1]	4,755	[2]
Net Book Value	8,133	[1]	8,975	[2]
Trademarks and Trade Names [Member]	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	5,365		5,401	[3]
Accumulated Amortization	119		37	[3]
Net Book Value	5,246		5,364	[3]
Customer Relationships [Member]	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	8,812	[4]	9,507	[5]
Accumulated Amortization	4,336	[4]	3,811	[5]
Net Book Value	4,476	[4]	5,696	[5]
Noncompete Agreements [Member]	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	160	[6]	220	[7]
Accumulated Amortization	75	[6]	65	[7]
Net Book Value	85	[6]	155	[7]
Website Development Costs [Member]	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Cost	8		'
Accumulated Amortization	0		'
Net Book Value	$8		'
[1]	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 were impaired by approximately $221,000 during 2013 (see Note 3 Impairment Charges) and the $17,000 of CTS patents remaining after the impairment is expected to be fully amortized in December 2021.
[2]	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Also includes patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 (see Note 3 Impairment Charges).
[3]	Includes a trade name obtained in the acquisition of CTS with an initial cost of $90,000 (see Note 3 Impairment Charges).
[4]	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Customer relationships obtained in the acquisition of CTS with a cost of $840,000 was impaired by approximately $780,000 (see Note 3 Impairment Charges) and the $60,000 of CTS customer relationships remaining after the impairment is expected to be fully amortized in December 2021.
[5]	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Also includes customer relationships obtained in the acquisition of CTS with a cost of $840,000 (see Note 3 Impairment Charges).
[6]	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 was determined to be fully impaired in 2013 (see Note 3 Impairment Charges).
[7]	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Also includes non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 (see Note 3 Impairment Charges).

Other_Intangible_Assets_Future

Other Intangible Assets (Future Amortization Expense Related To Other Intangible Assets) (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
2014	$1,970
2015	1,970
2016	1,959
2017	1,927
2018	1,889
Thereafter	7,011
Total future amortization expense	$16,726

Other_Intangible_Assets_Additi

Other Intangible Assets (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013		Dec. 31, 2012
Other Intangible Assets [Line Items]	'		'
Intangible Assets, Net (Excluding Goodwill)	$17,948,000		$20,190,000
Useful lives	'20 years		'
Amortization Of Intangible Assets	1,796,000		1,858,000
Trademarks [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Finite Lived Intangible Assets Cost Incurred To Create Or Defend	27,000		3,000
Patents [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Finite Lived Intangible Assets Cost Incurred To Create Or Defend	342,000		292,000
Noncompete Agreements [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Intangible Assets, Net (Excluding Goodwill)	85,000	[1]	155,000	[2]
Useful lives	'5 years		'
Customer Relationships [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Intangible Assets, Net (Excluding Goodwill)	4,476,000	[3]	5,696,000	[4]
Developed Technologies Including Patents [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Intangible Assets, Net (Excluding Goodwill)	8,133,000	[5]	8,975,000	[6]
Cyalume Specialty Products Inc [Member] | Patents [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	50,000		'
Cyalume Specialty Products Inc [Member] | Noncompete Agreements [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	160,000		160,000
Cyalume Specialty Products Inc [Member] | Customer Relationships [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	920,000		920,000
Combat Training Solutions Inc [Member] | Patents [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	221,000		'
Intangible Assets, Gross (Excluding Goodwill), Total	'		238,000
Intangible Assets, Net (Excluding Goodwill)	17,000		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	410,000		'
Combat Training Solutions Inc [Member] | Noncompete Agreements [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	140,000		140,000
Combat Training Solutions Inc [Member] | Trade Names [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	'		90,000
Combat Training Solutions Inc [Member] | Customer Relationships [Member]	'		'
Other Intangible Assets [Line Items]	'		'
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)	780,000		'
Intangible Assets, Net (Excluding Goodwill)	60,000		'
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total	$840,000		$840,000
[1]	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 was determined to be fully impaired in 2013 (see Note 3 Impairment Charges).
[2]	Includes non-compete agreement obtained in the acquisition of CSP with a cost of $160,000 that is expected to be fully amortized in August 2016. Also includes non-compete agreement obtained in the acquisition of CTS with an initial cost of $140,000 (see Note 3 Impairment Charges).
[3]	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Customer relationships obtained in the acquisition of CTS with a cost of $840,000 was impaired by approximately $780,000 (see Note 3 Impairment Charges) and the $60,000 of CTS customer relationships remaining after the impairment is expected to be fully amortized in December 2021.
[4]	Includes customer relationships obtained in the acquisition of CSP with a cost of $920,000 that is expected to be fully amortized in December 2019. Also includes customer relationships obtained in the acquisition of CTS with a cost of $840,000 (see Note 3 Impairment Charges).
[5]	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 were impaired by approximately $221,000 during 2013 (see Note 3 Impairment Charges) and the $17,000 of CTS patents remaining after the impairment is expected to be fully amortized in December 2021.
[6]	Includes a patent obtained in the acquisition of CSP with a cost of $50,000 that is expected to be fully amortized in August 2026. Also includes patents obtained in the acquisition of CTS with an initial cost of $410,000 and a December 31, 2012 gross value of approximately $238,000 (see Note 3 Impairment Charges).

Debt_Issuance_Costs_Additional

Debt Issuance Costs (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Amortization of Financing Costs	$113,000	$119,000
Unamortized Debt Issuance Expense	542,000	695,000
Interest Expense [Member]	'	'
Unamortized Debt Issuance Expense	$86,000	'

Accrued_Expenses_Schedule_Of_A

Accrued Expenses (Schedule Of Accrued Expenses) (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Accrued Expenses [Line Items]	'		'
Payroll-related	$1,145	[1]	$1,817	[1]
Interest	331		143
Professional fees	26		178
Other	399		413
Accounts Payable and Accrued Liabilities	2,059		2,583
Selway Capital [Member]	'		'
Accrued Expenses [Line Items]	'		'
Related party payable	$158	[2]	$32	[2]
[1]	Accrued payroll-related costs as of December 31, 2013 include approximately $534,000 of accrued severance costs. Accrued payroll-related costs as of December 31, 2012 include approximately $296,000 of accrued severance costs.
[2]	See Note 18 for a description of the agreement with Selway Capital, LLC.

Accrued_Expenses_Additional_In

Accrued Expenses (Additional Information) (Detail) (Employee Severance [Member], USD $)	Dec. 31, 2013	Dec. 31, 2012
Employee Severance [Member]	'	'
Accrued Expenses [Line Items]	'	'
Payroll-related	$534,000	$296,000

Lines_Of_Credit_Additional_Inf

Lines Of Credit (Additional Information) (Detail)	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
	USD ($)	EUR (€)	Td Bank N. [Member]	Td Bank N. [Member]
			USD ($)	USD ($)
Line of Credit Facility [Line Items]	'	'	'	'
Line of Credit Facility, Maximum Borrowing Capacity	$1,100,000	€ 800,000	$5,000,000	'
Line of Credit Facility, Interest Rate Description	'	'	'Interest is payable monthly and is determined based on (i) the Prime Rate, plus 3%	'
Line of Credit Facility, Interest Rate During Period	'	'	6.25%	'
Line of Credit Facility, Amount Outstanding	'	'	1,600,000	0
Line Of Credit Facility Borrowing Availability	$840,000	'	'	'

Notes_Payable_Outstanding_Note

Notes Payable (Outstanding Notes Payable) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Senior Debt - Term Loan	$6,023	$8,519
Senior Debt - Real Estate Loan	1,679	1,804
Subordinated Term Loan	8,659	8,500
Promissory Note Payable	1,075	0
Total	17,436	18,823
Less: Unamortized debt discount	-542	-695
Less: Current portion of notes payable, including current portion of unamortized debt discount	-1,925	-9,734
Notes payable, net of current portion	$14,969	$8,394

Notes_Payable_Carrying_Value_o

Notes Payable (Carrying Value of The Subordinated Term Loan) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Principal amount of loan	$8,659	$8,500
Less: unamortized debt discount	-424	-622
Notes and Loans Payable	$8,235	$7,878

Notes_Payable_Interest_Costs_F

Notes Payable (Interest Costs For The Subordinated Term Loan) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Subordinated Term Loan [Line Items]	'	'
Contractual interest coupon rate	$949	$951
Amortization of related debt discount and debt issuance costs	486	308
Total interest expense recognized	$1,435	$1,259

Notes_Payable_Future_Minimum_P

Notes Payable (Future Minimum Payments Due For Notes Payable) (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
2014	$2,116
2015	6,016
2016	8,874
2017	215
2018	215
Thereafter	0
Long-term Debt	$17,436

Notes_Payable_Additional_Infor

Notes Payable (Additional Information) (Detail) (USD $)

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

0 Months Ended

Nov. 19, 2013

Dec. 31, 2013

Dec. 31, 2012

Aug. 31, 2012

Nov. 19, 2013

Dec. 31, 2013

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 19, 2013

Dec. 19, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Dec. 19, 2013

Dec. 19, 2013

Jul. 29, 2010

Dec. 31, 2013

Promissory Notes Payable [Member]

Subordinated Term Loan [Member]

Subordinated Term Loan [Member]

Subordinated Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Term Loan [Member]

Swapped Portion Of Term Loan [Member]

Real Estate Loan [Member]

Real Estate Loan [Member]

Real Estate Loan [Member]

Real Estate Loan [Member]

Granite Creek Partners Agent Llc [Member]

Granite Creek Partners Agent Llc [Member]

Before Amendment [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Notes Payable [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

'

'

$148,000

'

'

'

'

$10,000

'

'

'

'

'

Percentage of Debt Hedged by Interest Rate Derivatives

'

'

'

'

'

'

'

'

'

'

'

'

60.00%

'

'

'

'

'

'

Debt modification cost

90,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Long term debt maturities, 2015

'

2,116,000

'

'

'

'

'

'

2,500,000

'

'

'

'

1,400,000

'

'

'

'

'

Description of Interest Rate Cash Flow Hedge Activities

'

'Interest on the 60% interest rate-swapped portion of the Term Loan was payable monthly and determined based on 1-month LIBOR, plus a margin percentage that is based on financial performance. The total interest rate on the swapped portion of the Term Loan was changed from 6.53% to 6.25% on December 19, 2013 and was 6.53% at December 31, 2012. Interest on the remaining 40% of the Term Loan was also payable monthly and was determined based on 1-month LIBOR (subject to a 2% interest rate floor) plus a margin percentage that was based on financial performance. At December 31, 2013 and 2012, the total interest rate on the portion of the Term Loan that was not subject to an interest rate hedging relationship was at 6.25% and 6.0%, respectively. The Term Loan is collateralized by all of the assets of CTI (except CTI’s equity interests in CTSAS, of which only 65% is collateral of the Term Loan) and is guaranteed by Cyalume.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Stated Percentage

'

'

12.00%

'

2.00%

'

'

'

'

6.53%

6.53%

6.25%

'

'

6.42%

6.42%

6.25%

'

'

Subordinated Borrowing, Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

11.00%

'

Debt Instrument Convertible Number Of Equity Instrument

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,666,667

'

Share Price

'

'

'

$2.34

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$0.69

Debt Instrument, Convertible, Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$3.19

'

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

'

'

'

'

'

'

160,000

'

'

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights

'

0.01

'

'

'

'

1.5

'

'

'

'

'

'

'

'

'

'

'

'

Amendment and adjustment to the fair value of warrants issued in conjunction with issuance of subordinated term loan recorded within warrant liability

'

241,000

94,000

'

'

-207,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization of Debt Discount (Premium)

'

520,000

368,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Interest Rate, Effective Percentage

'

'

'

'

'

13.00%

'

17.00%

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument Convertible If Converted Value Less Than Principal

'

1,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Impaired Financing Receivable, Unpaid Principal Balance, Total

'

6,800,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amount Of Debt Discount And Warrant Liability

'

241,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Issuance Of Loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,500,000

'

Common Stock To Purchase Of Warrants

'

455,514

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment

'

'

'

'

215,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

'

$8,659,000

$8,500,000

'

$1,075,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Related_Party_Transactions_Add

Related Party Transactions (Additional Information) (Detail) (USD $)	12 Months Ended			12 Months Ended			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Nov. 19, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012
			Series A Preferred Stock [Member]	Jfc [Member]	Jfc [Member]	Jfc [Member]	China Development Group Llc [Member]	Amended JFC Note [Member]	Amended JFC Note [Member]
									First Conversion [Member]
Related Party Transaction [Line Items]	'	'	'	'	'	'	'	'	'
Note payable due to related parties	$2,100,000	$2,100,000	'	'	'	'	'	'	'
Debt Instrument, Interest Rate, Stated Percentage	'	12.00%	'	'	'	'	'	'	'
Long-term Line of Credit	'	'	499,980	'	'	5,000,000	'	'	'
Related party equity method investment ownership percentage	'	'	'	'	'	'	50.00%	'	'
Related Party Transaction, Amounts of Transaction	'	'	'	'	'	'	310,000	'	'
Gains (Losses) on Extinguishment of Debt, Total	-2,142,000	0	'	'	'	'	'	2,100,000	'
Fair Value Adjustment of Warrants	525,000	0	'	'	'	'	'	'	'
Liabilities, Current, Total	22,559,000	15,434,000	'	'	'	'	'	'	'
Debt Conversion, Original Debt, Amount	'	'	'	'	'	'	'	1,000,000	499,980
Debt Instrument, Convertible, Conversion Price	'	'	'	'	'	'	'	$32.50	'
Debt Conversion, Description	'	'	'	'	'	'	'	'	'upon conversion of the first $499,980 of Amended JFC Note principal, JFC would receive: (1) warrants to purchase for each $6.50 of principal amount converted, ten shares of the Companys common stock, and (2) warrants to purchase for each $32.50 of principal amount converted, one share of Series A Preferred Stock
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right	'	'	'	'	73,009	'	'	'	'
Class Of Warrant Or Right, Exercise Price Of Warrants Or Rights	0.01	'	'	'	0.01	'	'	'	'
Stock Issued During Period, Shares, New Issues	'	'	'	350,000	'	'	'	'	'
Sale of Stock, Price Per Share	'	'	'	$0.69	'	'	'	'	'
Other Liabilities, Current	$242,000	$0	'	'	'	'	'	'	'
Class Of Warrant Or Right, Outstanding	'	'	'	'	54,000	'	'	'	'
Common Stock Closing Price	'less than $1.75	'	'	'	'	'	'	'	'

Capital_Lease_Obligations_Pres

Capital Lease Obligations (Present Value Of The Net Minimum Lease Payments) (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
2014	$17
2015	7
2016	0
2017	0
2018	0
Thereafter	0
Total minimum lease payments	24
Less: amount representing interest	-2
Present value of net minimum lease payments	$22

Income_Taxes_The_Components_of

Income Taxes (The Components of Income (Loss) Before Income Taxes) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Domestic	($18,866)	($54,153)
Foreign	175	966
Loss before income taxes	($18,691)	($53,187)

Income_Taxes_Benefit_From_Inco

Income Taxes (Benefit From Income Taxes Consisted) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Current:	'	'
Federal	$0	$0
State	160	0
Foreign	130	388
Deferred:	'	'
Federal	-2,678	-2,556
State	-595	-738
Foreign	-55	-63
Benefit from income taxes	($3,038)	($2,969)

Income_Taxes_The_Consist_of_De

Income Taxes (The Consist of Deferred Income Tax Assets And Liabilities) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]	'	'
Deferred tax assets, Current	$4,502	$1,300
Deferred tax assets, Non-current	4,943	5,873
Valuation allowance, Current	-2,747	-689
Valuation allowance, Non-current	-3,175	-3,185
Deferred tax liabilities, Current	-655	-648
Deferred tax liabilities, Non-current	-8,790	-9,735
Deferred tax assets (liabilities), Current	3,847	652
Deferred tax assets (liabilities), Noncurrent	-3,847	-3,862
Federal [Member]	'	'
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]	'	'
Deferred tax assets, Current	6,329	1,390
Deferred tax assets, Non-current	7,230	8,256
Deferred tax liabilities, Current	-477	-469
Deferred tax liabilities, Non-current	-6,615	-7,311
State [Member]	'	'
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]	'	'
Deferred tax assets, Current	886	563
Deferred tax assets, Non-current	868	786
Deferred tax liabilities, Current	-124	-122
Deferred tax liabilities, Non-current	-1,697	-1,886
Foreign [Member]	'	'
Schedule Of Deferred Income Tax Assets And Liabilities [Line Items]	'	'
Deferred tax assets, Current	34	36
Deferred tax assets, Non-current	20	16
Deferred tax liabilities, Current	-54	-57
Deferred tax liabilities, Non-current	($478)	($538)

Income_Taxes_Principal_Compone

Income Taxes (Principal Components Of Our Net Liability Representing Deferred Income Tax Balances) (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Intangible assets	($3,778)		($3,408)
Property, plant and equipment	-740		-752
U.S. loss carryforwards and tax credits, net	8,974	[1]	4,703	[1]
Subsidiary income	-1,671	[2]	-1,459	[2]
Stock-based compensation expense	968		725
Reserves, accruals and other	1,292		805
Change in warrants fair value	877		0
Valuation allowance	-5,922		-3,874
Interest rate swaps	0		50
Deferred Tax Assets, Net, Total	$0		($3,210)
[1]	The Company had federal net operating loss carryforwards amounting to approximately $13.3 million and $2.0 million at December 31, 2013 and 2012, respectively. The net operating loss carryforward at December 31, 2013 expires in fiscal years 2025 through 2033. Internal Revenue Code Section 382 limits utilization of these losses to $3.2 million per year. It is possible that future changes in ownership could result in changes to the amounts allowed by IRC Section 382. State net operating loss carryforwards amounted to approximately $2.0 million and $1.0 million as of December 31, 2013 and 2012, respectively.
[2]	A deferred tax liability has been recorded for income taxes which may become payable upon distribution of earnings of CTSAS, our French subsidiary. The estimated amount of tax that might be payable with regard to any distribution for foreign subsidiary earnings is reported net of foreign taxes paid, which are creditable against our domestic tax liability. We do not permanently reinvest our foreign subsidiarybs earnings. The Company continually evaluates our assertion; if our foreign business needs change, so may our assertion.

Income_Taxes_Principal_Compone1

Income Taxes (Principal Components Of Our Net Liability Representing Deferred Income Tax Balances) (Parenthetical) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
In Millions, unless otherwise specified			Maximum [Member]	Minimum [Member]
Deferred Tax Assets, Operating Loss Carryforwards, Domestic	$13.30	$2	'	'
Deferred Tax Assets, Operating Loss Carryforwards, State and Local	2	1	'	'
Limitations On Use Operating Loss Carryforwards	$3.20	'	'	'
Operating Loss Carryforwards Expiration Year	'	'	'2033	'2025

Income_Taxes_The_Federal_Statu

Income Taxes (The Federal Statutory Income Tax Rate Differs From Our Effective Tax Rate) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Provision for federal income taxes expected at 34% statutory rate	($6,355)	($18,083)
Increase (reduction) resulting from:	'	'
Tax on global activities	2	38
State income taxes, less federal income tax benefit	-287	-518
Exempt interest	728	0
Change in valuation allowance	3,507	0
Goodwill impairment loss	57	15,615
Prior year true up	-715	-33
Other	25	12
Benefit from income taxes	($3,038)	($2,969)

Derivative_Instruments_And_Hed2

Derivative Instruments And Hedging Activities (Schedule Of Derivatives Held) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Thousands, unless otherwise specified
Derivatives, Fair Value	'	'
Interest rate swaps	$0	($155)
Currency forward contract	$0	($14)

Derivative_Instruments_And_Hed3

Derivative Instruments And Hedging Activities (Effect of Derivative Instruments Designated As Cash Flow Hedges And Not Designated As Hedging Instruments) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Cash Flow Hedging [Member] | Interest Rate Swap [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) In AOCL	$97	[1]	$73	[2]
Gain (Loss) Reclassified	0	[3]	0	[4]
Gain (Loss) in Earnings	0	[5]	0	[6]
Not Designated as Hedging Instrument [Member] | Forward Currency Contracts [Member]	'		'
Derivative Instruments, Gain (Loss) [Line Items]	'		'
Gain (Loss) In AOCL	0	[1]	0	[2]
Gain (Loss) Reclassified	0	[3]	0	[4]
Gain (Loss) in Earnings	$0	[5]	($18)	[6]
[1]	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2013.
[2]	Amount recognized in accumulated other comprehensive loss (AOCL) (effective portion and net of taxes) during 2012.
[3]	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2013.
[4]	Amount of gain (loss) originally recorded in AOCL but reclassified from AOCL into earnings during 2012.
[5]	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2013.
[6]	Amount of gain (loss) recognized in earnings on the derivative (ineffective portion and amount excluded from effectiveness testing) reported in other income, net during 2012.

Derivative_Instruments_And_Hed4

Derivative Instruments And Hedging Activities (Effect of Derivative Instruments Designated As Cash Flow Hedges And Not Designated As Hedging Instruments) (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Derivative Instruments, Gain (Loss) [Line Items]	'	'
Gain (Loss) in AOCL, taxes	$59	$45

Recovered_Sheet2

Derivative Instruments and Hedging Activities (Additional Information) (Detail)	12 Months Ended
	Dec. 31, 2013
Derivative [Line Items]	'
Interest rate swap assumed hedge effectiveness	100.00%
Number of foreign currency forward contracts	1
Maximum [Member]	'
Derivative [Line Items]	'
Currency forward contract, duration	'6 months

Asset_Retirement_Obligation_Th

Asset Retirement Obligation (The Significant Assumptions Used To Estimate The Obligation) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Asset Retirement Obligation Disclosure [Line Items]	'
Annual inflation rate	5.54%
Credit-adjusted risk-free rate	5.37%
Initial estimated remediation costs (undiscounted and not adjusted for inflation)	$200,000
Estimated remediation completion date	19-Dec-38
Estimated remediation cost on December 19, 2038	$720,000

Asset_Retirement_Obligation_Re

Asset Retirement Obligation (Reconciliation of The Beginning And Ending Aggregate Carrying Amounts Of The Asset Retirement Obligation) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Asset Retirement Obligation Disclosure [Line Items]	'		'
Balance, beginning	$184		$175
Accretion expense	10		9
Balance, ending	$194	[1]	$184
[1]	The difference between the $194,000 liability as of December 31, 2013 and the estimated undiscounted future payments of $720,000 is estimated inflation between December 31, 2013 and December 19, 2038.

Asset_Retirement_Obligation_Re1

Asset Retirement Obligation (Reconciliation of The Beginning And Ending Aggregate Carrying Amounts Of The Asset Retirement Obligation) (Parenthetical) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2007
Asset Retirement Obligation Disclosure [Line Items]	'
Undiscounted and not adjusted for inflation	$41,000

Commitments_And_Contingencies_1

Commitments And Contingencies (Future Minimum Lease Payments) (Detail) (USD $)	Dec. 31, 2013
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Line Items]	'
2014	$687
2015	628
2016	483
2017	238
2018	59
Thereafter	0
Operating Leases, Future Minimum Payments Due	$2,095

Commitments_And_Contingencies_2

Commitments And Contingencies (Additional Information) (Detail) (USD $)

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

12 Months Ended

1 Months Ended

0 Months Ended

12 Months Ended

Dec. 31, 2013

Dec. 31, 2012

Aug. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Nov. 19, 2013

Nov. 20, 2013

Dec. 31, 2013

Nov. 19, 2013

Dec. 31, 2013

Nov. 19, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Jul. 18, 2011

Jul. 18, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Selway Capital, LLC [Member]

Other Assets [Member]

Cts [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Mr.Colon [Member]

Selwaybs [Member]

Selwaybs [Member]

Legal Obligation and Other Costs [Member]

Legal Obligation [Member]

Omniglow [Member]

Omniglow [Member]

Newmark Knight and Frank [Member]

Operating Leases [Member]

Operating Leases [Member]

Maximum [Member]

Promissory Note [Member]

Land [Member]

Five Year Annal Installments [Member]

Subsequent Event [Member]

Attorney Fees and Costs [Member]

Commitments and Contingencies Disclosure [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Note payable due to related parties

$2,100,000

$2,100,000

'

'

'

'

'

'

'

'

'

'

$21,000

$11,000

'

'

'

'

'

'

'

Loss Contingency, Damages Awarded, Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,600,000

235,000

'

'

'

Prejudgment Interest Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

12.00%

12.00%

'

'

'

Loss contingency damages awarded accrued interest

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,300,000

'

'

'

'

Loss Contingency, Accrual Carrying Value, Current

4,300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

3,600,000

4,000,000

'

'

'

'

'

Future Minimum Lease Payments, Required Per Month

'

'

24,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

30,000

'

'

Payment of contingent consideration from the CTS acquisition

'

'

'

'

'

5,750,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Operating Leases, Rent Expense

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

638,000

439,000

Litigation Settlement, Amount

'

'

'

'

'

'

1,075,000

'

'

'

'

215,000

'

'

'

'

'

'

'

'

'

Payments for Legal Settlements

-2,038,000

0

'

'

'

'

'

275,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Legal Settlement Costs

2,048,000

0

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Legal Settlement Assets Transfer Value

'

'

'

'

'

'

'

'

'

'

631,000

'

'

'

'

'

'

'

'

'

'

Legal Settlement Tax On Assets Transfer

'

'

'

'

'

'

'

'

'

'

63,000

'

'

'

'

'

'

'

'

'

'

Legal Settlement Notes Issued

'

'

'

'

'

'

'

'

'

1,075,000

'

'

'

'

'

'

'

'

'

'

'

Interest Payable, Current

275,000

'

'

158,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Provision for Doubtful Accounts

3,862,000

0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Escrow Shares Fair Value

'

'

'

'

625,139

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Loss Contingency Accrual, Beginning Balance

$4,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred_Stock_Schedule_Of_Co

Preferred Stock (Schedule Of Common Warrants) (Detail) (USD $)	Aug. 31, 2012	Dec. 31, 2013
		Common Warrant [Member]
		Number
Class of Warrant or Right [Line Items]	'	'
Fair value assumptions method used	'	'Monte Carlo simulation method
Stock price of underlying equity	$2.34	$0.69
Exercise price	'	$0.65
Expected volatility (standard deviation)	'	100.00%
Annual risk-free rate	'	3.04%
Expected term (time to expiration years)	'	'9 years 10 months 24 days
Number of periods	'	514
Period interval	'	0.019
Period risk-free rate	'	0.06%
Number of simulations	'	500,000

Preferred_Stock_Schedule_Of_Pr

Preferred Stock (Schedule Of Preferred Warrants) (Detail) (USD $)	Dec. 31, 2013	Aug. 31, 2012	Dec. 31, 2013
			Preferred Warrant [Member]
Class of Warrant or Right [Line Items]	'	'	'
Stock price of underlying equity	'	$2.34	$32.50
Exercise price	0.01	'	0.05
Expected term (years)	'	'	'1 year 8 months 12 days
Risk-free interest rate	'	'	0.13%
Estimated dividend yield	'	'	'
Volatility	'	'	70.00%

Preferred_Stock_Schedule_Of_Ch

Preferred Stock (Schedule Of Change In The Fair Value Of The Warrants Liability) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]	'	'
Warrant liability at December 31, 2012	$0	'
Fair value recorded on the November 19, 2013 transaction date	5,848	'
Change in fair value of warrants	525	0
Warrant liability at December 31, 2013	6,373	0
Common Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrant liability at December 31, 2012	0	'
Fair value recorded on the November 19, 2013 transaction date	3,556	'
Change in fair value of warrants	525	'
Warrant liability at December 31, 2013	4,081	'
Preferred Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrant liability at December 31, 2012	0	'
Fair value recorded on the November 19, 2013 transaction date	1,997	'
Change in fair value of warrants	0	'
Warrant liability at December 31, 2013	1,997	'
JFC Warrant [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrant liability at December 31, 2012	0	'
Fair value recorded on the November 19, 2013 transaction date	54	'
Change in fair value of warrants	0	'
Warrant liability at December 31, 2013	54	'
Subordinated Term Loan Warrants [Member]	'	'
Class of Warrant or Right [Line Items]	'	'
Warrant liability at December 31, 2012	0	'
Fair value recorded on the November 19, 2013 transaction date	241	'
Change in fair value of warrants	0	'
Warrant liability at December 31, 2013	$241	'

Preferred_Stock_Additional_Inf

Preferred Stock (Additional Information) (Detail) (USD $)	12 Months Ended						1 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Nov. 19, 2013	Dec. 31, 2013	Nov. 19, 2013	Nov. 19, 2013	Nov. 19, 2013
		Series A Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Common Warrant [Member]	Preferred Warrant [Member]	Preferred Warrant [Member]	Purchase Agreement [Member]	Purchase Agreement [Member]
				Series A Preferred Stock [Member]		Series A Preferred Stock [Member]		Series A Convertible Preferred Stock [Member]
Preferred Stock Disclosure [Line Items]	'	'	'	'	'	'	'	'
Preferred Stock, Shares Authorized	1,000,000	1,000,000	1,000,000	'	'	'	'	'
Stock Issued During Period, Shares, Other	'	'	'	'	'	'	123,077	'
Stock Issued During Period, Value, Other	'	'	'	'	'	'	$4,000	'
Sale of Stock, Price Per Share	'	'	'	'	'	'	$32.50	'
Preferred Stock Par Or Stated Value Per Share	'	$0.00	$0.00	'	'	'	'	$0.00
Preferred Stock, Liquidation Preference Per Share	$32.50	'	'	'	'	'	'	'
Convertible Preferred Stock, Shares Issued upon Conversion	50	'	'	'	'	'	'	'
Convertible Preferred Stock Conversion price	$0.65	'	'	'	'	'	'	'
Percentage Of Dividend Payable On Basis Of Liquidation Preference	12.00%	'	'	'	'	'	'	'
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights	'	'	'	6,153,830	'	123,077	'	'
Exercise price	0.01	'	'	0.65	0.05	0.05	'	'

Stockholders_Equity_Warrants_T

Stockholders' Equity (Warrants To Purchase Common Stock Outstanding) (Detail)	12 Months Ended
	Dec. 31, 2013
Class of Warrant or Right [Line Items]	'
Exercise price	0.01
US VC Partners, L.P [Member]	'
Class of Warrant or Right [Line Items]	'
Number of Shares Exercisable Under Warrant	6,153,850
Exercise price	0.65
Expiration Date	19-Nov-23
JFC Technologies LLC [Member]	'
Class of Warrant or Right [Line Items]	'
Number of Shares Exercisable Under Warrant	73,009
Exercise price	0.01
Expiration Date	19-Nov-23
Granite Creek FlexCap I, L.P [Member]	'
Class of Warrant or Right [Line Items]	'
Number of Shares Exercisable Under Warrant	267,950
Exercise price	0.01
Expiration Date	19-Nov-23
Patriot Capital II, L.P [Member]	'
Class of Warrant or Right [Line Items]	'
Number of Shares Exercisable Under Warrant	187,564
Exercise price	0.01
Expiration Date	19-Nov-23

Stockholders_Equity_ShareBased

Stockholders' Equity (Share-Based Expenses Are Included In Our Consolidated Statements Of Comprehensive Income (Loss) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	$773	$503
Cost of Sales [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	9	12
Selling and Marketing Expense [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	44	-12
General and Administrative Expense [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	621	387
Research and Development Expense [Member]	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock-based compensation expense	$99	$116

Stockholders_Equity_The_BlackS

Stockholders' Equity (The Black-Scholes Pricing Model With The Following Assumptions For Awards To Employees And Non-Employees) (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Risk-free interest rate (Minimum)	1.10%	0.73%
Risk-free interest rate (Maximum)	1.70%	1.43%
Estimated dividend yield	0.00%	0.00%
Volatility (Minimum)	126.71%	26.45%
Volatility (Maximum)	130.08%	128.16%
Maximum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected term (years)	'6 years 6 months	'6 years 6 months
Minimum [Member]	'	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'	'
Expected term (years)	'5 years	'5 years

Stockholders_Equity_Stock_Opti

Stockholders' Equity (Stock Option And Warrant Activity Related To Share-Based Compensation) (Detail) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Outstanding Shares, Beginning	2,842		1,166
Shares Granted	708	[1]	1,708	[2]
Shares Exercised	0		-5	[3]
Shares Forfeited	-255		-24
Shares Expired	-283		-3
Outstanding Shares, Ending	3,012	[4]	2,842
Shares Exercisable	1,321	[5]	'
Outstanding Weighted Average Exercise Price, Beginning	$2.33		$3.44
Weighted Average Exercise Price Granted	$1.79	[1]	$1.60	[2]
Weighted Average Exercise Price Exercised	$0		$3.65	[3]
Weighted Average Exercise Price Forfeited	$2.02		$3.71
Weighted Average Exercise Price Expired	$3.78		$3.80
Outstanding Weighted Average Exercise Price, Ending	$2.09		$2.33
Weighted Average Exercise Price Exercisable	$2.76		'
[1]	The weighted-average grant-date fair value of awards granted was $1.61.
[2]	The weighted-average grant-date fair value of awards granted was $1.33.
[3]	The intrinsic value of awards exercised was $1,000. These options were exercised on a cashless basis, therefore no cash was received at exercise. The tax benefit realized from this exercise was insignificant.
[4]	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013.
[5]	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013. The weighted-average remaining contractual term for these options is 6.45 years as of December 31, 2013.

Stockholders_Equity_Stock_Opti1

Stockholders' Equity (Stock Option And Warrant Activity Related To Share-Based Compensation) (Parenthetical) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Weighted-average grant-date fair value	$1.61	$1.33
Intrinsic value of awards exercised	'	$1,000

Stockholders_Equity_Stock_Opti2

Stockholders' Equity (Stock Options And Warrants Related To Stock-Based Compensation) (Detail) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012	Dec. 31, 2011
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'		'	'
Number Outstanding (in thousands)	3,012	[1]	2,842	1,166
Options Outstanding Weighted Average Remaining Contractual Term (Years)	'7 years 9 months 7 days		'	'
Options Outstanding Weighted Average Exercise Price	$2.09		$2.33	$3.44
Options Exercisable Number Exercisable (in thousands)	1,321	[2]	'	'
Options Exercisable Weighted Average Exercise Price	$2.76		'	'
Range Of Exercise Prices 0.00 - 2.00 [Member]	'		'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'		'	'
Number Outstanding (in thousands)	2,212		'	'
Options Outstanding Weighted Average Remaining Contractual Term (Years)	'8 years 3 months 18 days		'	'
Options Outstanding Weighted Average Exercise Price	$1.57		'	'
Options Exercisable Number Exercisable (in thousands)	545		'	'
Options Exercisable Weighted Average Exercise Price	$1.69		'	'
Range Of Exercise Prices 2.01 - 4.00 [Member]	'		'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'		'	'
Number Outstanding (in thousands)	675		'	'
Options Outstanding Weighted Average Remaining Contractual Term (Years)	'6 years 2 months 5 days		'	'
Options Outstanding Weighted Average Exercise Price	$3.34		'	'
Options Exercisable Number Exercisable (in thousands)	668		'	'
Options Exercisable Weighted Average Exercise Price	$3.33		'	'
Range Of Exercise Prices 4.01 - 6.00 [Member]	'		'	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'		'	'
Number Outstanding (in thousands)	125		'	'
Options Outstanding Weighted Average Remaining Contractual Term (Years)	'6 years 11 months 8 days		'	'
Options Outstanding Weighted Average Exercise Price	$4.61		'	'
Options Exercisable Number Exercisable (in thousands)	108		'	'
Options Exercisable Weighted Average Exercise Price	$4.61		'	'
[1]	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013.
[2]	The aggregate intrinsic value of these stock options and warrants is $0 as of December 31, 2013. The weighted-average remaining contractual term for these options is 6.45 years as of December 31, 2013.

Stockholders_Equity_Stock_Opti3

Stockholders' Equity (Stock Options And Warrants Related To Stock-Based Compensation) (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Options Outstanding, Intrinsic Value	$0
Options Exercisable, Intrinsic Value	$0
Options Exercisable, Weighted-average remaining contractual term	'6 years 5 months 12 days

Stockholders_Equity_Nonvested_

Stockholders' Equity (Nonvested Restricted Common Stock Related To Stock-Based Compensation (Detail) (USD $)	12 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Shares Outstanding, Beginning	36	[1]	277
Shares Granted	0		29
Shares Vested	-36	[2]	-129	[3]
Shares Forfeited	0		-141
Shares Outstanding, Ending	0		36	[1]
Outstanding Weighted Average Grant Date Fair Value, Beginning	$3.76		$3.88
Weighted Average Grant Date Fair Value Granted	$0		$2.66
Weighted Average Grant Date Fair Value Vested	$3.76	[2]	$3.53	[3]
Weighted Average Grant Date Fair Value Forfeited	$0		$3.98
Outstanding Weighted Average Grant Date Fair Value, Ending	$0		$3.76
[1]	These stock awards vested upon fulfilling service conditions.
[2]	The total fair value of restricted common stock awards that vested during 2013 was $45,000.
[3]	The total fair value of restricted common stock awards that vested during 2012 was $364,000.

Stockholders_Equity_Nonvested_1

Stockholders' Equity (Nonvested Restricted Common Stock Related To Stock-Based Compensation (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Stock Issued During Period, Value, Restricted Stock Award, Forfeitures	$45	$364

Stockholders_Equity_Accumulate

Stockholders' Equity (Accumulated other comprehensive loss) (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Thousands, unless otherwise specified
Foreign currency translation loss	($218)	($418)	($526)
Unrealized gain on cash flow hedges, net of taxes	0	-97	-170
Accumulated other comprehensive loss	($218)	($515)	'

Stockholders_Equity_Changes_In

Stockholders' Equity (Changes In Accumulated Other Comprehensive Loss Due To Derivative Instruments And Hedging Activities) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Beginning balance	($97)	($170)
Unrealized gain on interest rate swaps, net of taxes of $(45) and $(59), respectively	97	73
Ending balance	$0	($97)

Stockholders_Equity_Changes_In1

Stockholders' Equity (Changes In Accumulated Other Comprehensive Loss Due To Derivative Instruments And Hedging Activities) (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Unrealized gain on interest rate swaps, tax portion	($59)	($45)

Stockholders_Equity_Changes_In2

Stockholders' Equity (Changes In Accumulated Other Comprehensive Loss Due To Currency Translation Adjustments) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Beginning balance	($418)	($526)
Adjustments due to translation of CTSAS financial statements from Euros into U.S. Dollars	200	108
Ending balance	($218)	($418)

Stockholders_Equity_Additional

Stockholders' Equity (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Stockholders Equity Additional Information [Line Items]	'	'
Common stock, shares authorized	100,000,000	100,000,000
Stock-based compensation expense	$773,000	$503,000
Exercise price	0.01	'
Senior Amendment [Member]	'	'
Stockholders Equity Additional Information [Line Items]	'	'
Debt Issuance Cost	199,000	'
Exercise price	0.01	'
Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights	455,514	'
Unrestricted Stock Awards [Member]	'	'
Stockholders Equity Additional Information [Line Items]	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	'	2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	'	2,650,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	848,666	'
Stock Option And Warrant Awards [Member]	'	'
Stockholders Equity Additional Information [Line Items]	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	1,773,000	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition	'3 years 8 months 5 days	'
Stock Awards [Member]	'	'
Stockholders Equity Additional Information [Line Items]	'	'
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	'	$52,000
Subordinated Debt [Member]	'	'
Stockholders Equity Additional Information [Line Items]	'	'
Class of Warrant or Right, Outstanding	'	160,000

Employee_Benefit_Plans_Additio

Employee Benefit Plans (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]	'	'
Description of Defined Contribution Pension and Other Postretirement Plans	'The CTI Employee Savings and Retirement Plan (the ESRP), is intended to be qualified under Section 401(k) of the Internal Revenue Code. Employees of CTI, CTS and CSP who have reached the age of 18 are eligible for participation on the first entry date after three months of service. Entry dates are the first day of January, April, July and October. Employees may defer receiving compensation up to the maximum amount permitted under the Internal Revenue Code. Matching contributions to the ESRP equal (i) 3% of employee compensation plus (ii) 50% of the next 2% of employee compensation. For the years ended December 31, 2013 and 2012, employer matching contributions were $263,000 and $242,000, respectively.	'
Defined Contribution Plan Employer Matching Contribution Annual Amount	$263,000	$242,000
Defined Benefit Plan, Benefit Obligation	$79,000	'

Concentrations_Additional_Info

Concentrations (Additional Information) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk [Line Items]	'	'
Insurance Coverage	250,000	'
Cash, Uninsured Amount	328,000	'
Insurance Coverage Exceed Limits	90,000	'
Outside United States Customer [Member] | Sales [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	32.00%	28.00%
CTSAS [Member]	'	'
Concentration Risk [Line Items]	'	'
Assets, Net	5,245,000	6,278,000
United Kingdom [Member]	'	'
Concentration Risk [Line Items]	'	'
Percentage Of Revenues From Customers	5.00%	9.00%
One Customers [Member] | Sales [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	23.00%	'
Three Customers [Member]	'	'
Concentration Risk [Line Items]	'	'
Accounts Receivable Gross Percentage	47.00%	39.00%
Two Customers [Member] | Sales [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	'	40.00%
Other Customer [Member]	'	'
Concentration Risk [Line Items]	'	'
Accounts Receivable Gross Percentage	10.00%	10.00%

Recovered_Sheet3

Fair Values Of Assets And Liabilities (Assets And Liabilities Measured At Fair Value On Recurring Basis) (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
In Thousands, unless otherwise specified
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	($6,373)		($169)
Interest Rate Swap [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	-155	[1]
Currency forward contracts [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[2]	-14	[2]
Warrants [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	-6,373	[3]	'
Level 1 Quoted Prices in Active Markets for Identical Assets [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0		0
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Interest Rate Swap [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	0	[1]
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Currency forward contracts [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[2]	0	[2]
Level 1 Quoted Prices in Active Markets for Identical Assets [Member] | Warrants [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[3]	'
Level 2 Significant Other Observable Inputs [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0		-169
Level 2 Significant Other Observable Inputs [Member] | Interest Rate Swap [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	-155	[1]
Level 2 Significant Other Observable Inputs [Member] | Currency forward contracts [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[2]	-14	[2]
Level 2 Significant Other Observable Inputs [Member] | Warrants [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[3]	'
Level 3 Significant Unobservable Inputs [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	-6,373		0
Level 3 Significant Unobservable Inputs [Member] | Interest Rate Swap [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[1]	0	[1]
Level 3 Significant Unobservable Inputs [Member] | Currency forward contracts [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	0	[2]	0	[2]
Level 3 Significant Unobservable Inputs [Member] | Warrants [Member]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis [Line Items]	'		'
Fair Value Assets And Liabilities Measured On Recurring Basis	($6,373)	[3]	'
[1]	The fair values of the swaps are determined by discounting the estimated cash flows to be received and paid due to the swaps over the swapbs contractual lives using an estimated risk-free interest rate for each swap settlement date (an income approach).
[2]	The fair value of these contracts is determined by multiplying the notional amount of the contract by the difference between (a) the U.S. dollar amount due on the contract at maturity and (b) the foreign exchange rate as of the date the contract is valued (the balance sheet date). Because the contracts typically have a short duration, the value is not discounted using a present value technique (an income approach).
[3]	The Company has classified its warrants liability which could be potentially settled in cash within Level 3 because the fair values are determined using significant unobservable inputs into the Black-Scholes pricing model.

Recovered_Sheet4

Fair Values Of Assets And Liabilities (Consideration Liability Measured at Fair Value on Recurring Basis) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Commitments consideration [Member]	'	'
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'
Balance at the beginning of period	$0	($3,699)
Initial recognition of the liabilities	0	0
Unrealized gains (losses) in earnings	0	-3,380
Finalization of the fair value determination of contingent consideration in the CTS acquisition	0	-166
Payment of contingent consideration from the CSP acquisition	0	7,245
Balance at the end of period	0	0
Warrants Liability [Member]	'	'
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]	'	'
Balance at the beginning of period	0	0
Fair value recorded on the November 19, 2013 transaction date	5,848	0
Change in fair value of warrants	525	0
Balance at the end of period	$6,373	$0

Fair_Values_Of_Assets_And_Liab2

Fair Values Of Assets And Liabilities (Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Goodwill [Member] | Training [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	$168	[1],[2]	$858	[1],[2]
Fair Value	0	[1],[2]	351	[1],[2]
Goodwill [Member] | Chemical Light [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	'		46,230	[1],[2]
Fair Value	'		5,014	[1],[2]
Patents [Member] | Training [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	174	[1],[3]	172	[1],[3]
Fair Value	17	[1],[3]	210	[1],[3]
Trade Names [Member] | Training [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	17	[1],[4]	29	[1],[4]
Fair Value	0	[1],[4]	30	[1],[4]
Non Compete Agreement [Member] | Training [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	34	[1],[5]	80	[1],[5]
Fair Value	0	[1],[5]	40	[1],[5]
Customer Relationships [Member] | Training [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	650	[1],[6]	'
Fair Value	60	[1],[6]	'
Certain Equipment [Member] | Chemical Light [Member]	'		'
Fair Value, Assets Measured on Non-Recurring Basis, Unobservable Input Reconciliation	'		'
Loss Recognized	'		273	[1],[6]
Fair Value	'		$0	[1],[6]
[1]	The Company managed as one operating segment with four reporting units: Chemical Light (the operations of CTI and CTSAS), CTS Training (the operations of CTS), Specialty Products (the operations of CSP) and Other (the operations of CRI and the parent company Cyalume Technologies Holdings, Inc.). Specialty Productsb goodwill was not considered to be impaired and our Other reporting unit does not have a goodwill asset.
[2]	The fair value of the impaired goodwill asset was determined calculating the excess of the fair value of the reporting unit over the fair values assigned to its assets and liabilities and utilized present value techniques utilizing each reporting unitbs forecasted after-tax cash flows.
[3]	The fair value of the impaired patent asset was determined using the brelief from royaltyb method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the patents, net of estimated income taxes (an income approach).
[4]	The fair value of the impaired trademarks and trade names asset was determined using the brelief from royaltyb method, which calculates the present value of a stream of estimated future royalty payments that an entity would be willing to pay in order to utilize the trademarks and trade names, net of estimated income taxes (an income approach).
[5]	The fair value of the impaired non-compete agreement asset was determined using the bcomparative business valuationb method, which compares the present value of two streams of the reporting unitbs estimated future cash flows; one stream assuming the non-compete agreements are in place and the other stream assuming the agreements are not in place (an income approach).
[6]	The fair value of the impaired equipment was determined estimating the present value of cash flows expected to result from the use and disposition of the equipment (an income approach).

Recovered_Sheet5

Supplemental Disclosure Of Cash Flow Information (Cash Paid for Interest and Income Taxes) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Interest	$1,693	$1,762
Income taxes	$133	$554

Recovered_Sheet6

Supplemental Disclosure Of Cash Flow Information (Non-Cash Investing and Financing Activities) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Non-Cash Investing And Financing Activities [Line Items]	'	'
Series A Convertible Preferred stock in-kind dividend	$55	$0
Series A Convertible Preferred stock deemed dividend	4,000	0
Warrants liability recorded in connection with common and preferred warrants	5,607	0
Amendment and adjustment to the fair value of warrants issued in conjunction with issuance of subordinated term loan recorded within warrant liability	241	94
Adjustment to goodwill acquired and contingent consideration incurred in the acquisition of CTS due to the finalization of the fair value of the contingent consideration	0	166
Adjustment to goodwill acquired and deferred tax liability incurred in the acquisition of CTS due to the finalization of the fair value of the business combination	0	64
Adjustment to CTS goodwill due to the current period reduction of its deferred tax liability associated with the current period impairment of identified intangible assets	0	183
Issuance of 2,450,000 shares of our common stock to repay the contingent consideration liability resulting from the acquisition of CSP	0	5,145
Issuance of a $2,100,000 note payable to repay the contingent consideration liability resulting from the acquisition of CSP	0	2,100
Issuance of 22,500 shares of our common stock to settle litigation claim	$0	$56

Supplemental_Disclosure_Of_Cas2

Supplemental Disclosure Of Cash Flow Information (Non-Cash Investing and Financing Activities) (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2012
Non-Cash Investing And Financing Activities [Line Items]	'
Stock Issued During Period Shares To Settle Litigation	22,500
Cyalume Specialty Products [Member]	'
Non-Cash Investing And Financing Activities [Line Items]	'
Debt Instrument Issued For Repayment Contingent Consideration Liability	2,100,000
Stock Issued During Period Shares Contingent Consideration Liability	2,450,000

Valuation_And_Qualifying_Accou

Valuation And Qualifying Accounts (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Allowance for Doubtful Accounts [Member]	'		'
Valuation and Qualifying Accounts Disclosure [Line Items]	'		'
Balance at Beginning of Period	$155		$206
Additions Charged to costs and expenses	2		-1
Additions Charged to other accounts (Describe)	0		0
Deductions (Describe)	-113	[1]	-50	[2]
Balance at End of Period	44		155
Deferred Tax Asset Valuation Allowance [Member]	'		'
Valuation and Qualifying Accounts Disclosure [Line Items]	'		'
Balance at Beginning of Period	3,874		3,874
Additions Charged to costs and expenses	2,048		0
Additions Charged to other accounts (Describe)	0		0
Deductions (Describe)	0		0
Balance at End of Period	$5,922		$3,874
[1]	Write-offs and recoveries
[2]	Write-offs ($49,000) and recoveries of reserved receivables ($1,000)

Valuation_And_Qualifying_Accou1

Valuation And Qualifying Accounts (Parenthetical) (Detail) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013
Valuation and Qualifying Accounts Disclosure [Line Items]	'
Allowance for Doubtful Accounts Receivable, Write-offs	($49,000)
Allowance for Doubtful Accounts Receivable, Recoveries	($1,000)